<!doctype html><html lang="en"><head><meta charset="utf-8"> <title>Biology Beyond Barriers - Interview with Don Ingber</title> <meta name="viewport" content="width=device-width,initial-scale=1,viewport-fit=cover"> <meta name="description" content="The man who coined Eroom’s law, on the end of an era in drug R&amp;D, the frontier of drug discovery, and COVID-19."> <meta name="theme-color" content="#061E29"> <link rel="alternate" href="/feed.xml" type="application/atom+xml"> <link rel="apple-touch-icon" href="/apple-touch-icon.png"><link rel="icon" href="/favicon.png" type="image/png"><link rel="icon" href="data:image/svg+xml;utf8,%3Csvg%20width%3D'256'%20height%3D'256'%20xmlns%3D'http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg'%3E%3Cg%20fill%3D'none'%20fill-rule%3D'evenodd'%3E%3Cpath%20fill%3D'%23061E29'%20d%3D'M0%200h256v256H0z'%2F%3E%3Cpath%20d%3D'M113.2%20113H87V63.4H136c10.3%200%2020.9.2%2029.9%206a34.8%2034.8%200%200114.8%2029c0%2013.2-7.7%2025.4-20.2%2030l26.9%2065h-30L134%20133.9H73l-15.6-19.1h70.7c5.7%200%2011.9.5%2016.8-2.4%204.5-2.7%206.9-8.2%206.9-13.3%200-4.6-2.8-9.6-6.7-12-4.6-2.9-12.5-2.2-17.6-2.2h-14.4v28zm1%2022.7v44.2H86.8v-44.2H114z'%20fill%3D'%23FFF'%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E" sizes="any" type="image/svg+xml"><link rel="mask-icon" href="/mask-icon.svg" color="#061E29"> <link rel="manifest" href="/manifest.json"> <style>:root{--fontstack-prefix:-apple-system,BlinkMacSystemFont,;--fontstack-sans-serif:"Helvetica Neue",sans-serif;--fontstack-serif:Georgia,serif;--fontstack-monospace:Menlo,Consolas,monospace;--fontstack-default:var(--fontstack-prefix) var(--fontstack-sans-serif);--font-size:1.6vw;--font-features:"halt","ss01","ss02";--line-height:calc(20 / 14);--heading-letter-spacing:-.04em;--breakpoint-lg:1600px;--breakpoint-md:1080px;--breakpoint-sm:640px;--breakpoint-xs:400px;--space-lg:24vw;--space-md:8vw;--space-sm:4vw;--space-xs:1.2vw;--border-lg:4px;--border-md:2px;--border-sm:1px;--link-color:#03549b;--background-color:#fff;--text-color:#000;--code-color:#3914b3;--nav-padding:.75vmax;--nav-item-space:1.4vmax}*,::after,::before{padding:0;margin:0;box-sizing:border-box}html{font-size:100%;-webkit-text-size-adjust:none;-ms-text-size-adjust:none;text-size-adjust:none;text-rendering:optimizelegibility;image-rendering:optimizequality;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;background:var(--bg-color)}body{--space-body:var(--space-lg);padding-top:0;padding-bottom:0;padding-left:var(--space-body);padding-right:var(--space-body);margin:0 auto 0;font-family:var(--fontstack-default);font-size:var(--font-size);font-feature-settings:var(--font-features);line-height:var(--line-height);hanging-punctuation:first allow-end;color:var(--text-color);background:var(--bg-color);-webkit-transition:all .2s ease;transition:all .2s ease}@media (max-width:1080px){body{--space-body:var(--space-md);font-size:calc(var(--font-size) * 1.4)}}@media (max-width:640px){body{--space-body:var(--space-sm);font-size:calc(var(--font-size) * 2.4)}}@media (max-width:400px){body{font-size:calc(var(--font-size) * 3.2)}}button,input,select,textarea{color:inherit;font-family:inherit;font-size:inherit;line-height:inherit}button,input,select[multiple],textarea{background-image:none}a,button{color:var(--text-color);text-decoration:none;-webkit-transition:color .5s ease,border-color .5s ease,background .5s ease,opacity 1.5s ease;transition:color .5s ease,border-color .5s ease,background .5s ease,opacity 1.5s ease}a:focus,a:hover,button:focus,button:hover{-webkit-transition:color .1s ease,border-color .1s ease,background .1s ease,opacity .1s ease;transition:color .1s ease,border-color .1s ease,background .1s ease,opacity .1s ease;text-decoration:underline}a[disabled],button[disabled]{opacity:.4;cursor:not-allowed}button{-webkit-appearance:none;-moz-appearance:none;appearance:none;cursor:pointer;background:0 0;border:none;outline:0}hr,img{border:0}del{text-decoration:line-through}::-webkit-input-placeholder{color:var(--text-color);opacity:.2}::-moz-placeholder{color:var(--text-color);opacity:.2}:-ms-input-placeholder{color:var(--text-color);opacity:.2}::-ms-input-placeholder{color:var(--text-color);opacity:.2}::placeholder{color:var(--text-color);opacity:.2}:focus::-webkit-input-placeholder{color:var(--link-color)}:focus::-moz-placeholder{color:var(--link-color)}:focus:-ms-input-placeholder{color:var(--link-color)}:focus::-ms-input-placeholder{color:var(--link-color)}:focus::placeholder{color:var(--link-color)}.navigation{padding-top:var(--nav-padding);padding-bottom:var(--nav-padding);margin-right:calc(var(--nav-item-space) * -1);margin-left:calc(var(--nav-item-space) * -1);font-size:90%;font-weight:700}.navigation li{display:inline-block;line-height:2}.navigation li a{padding:.5em var(--nav-item-space)}.navigation li a:focus,.navigation li a:hover{color:var(--link-color);text-decoration:none}.current a{color:var(--link-color)}body:hover .latest{color:var(--link-color)!important}.content{margin-bottom:16vmin}.content::after,.content::before{display:table;content:""}.content::after{clear:both}.content article>:last-child{margin-bottom:0!important}.content article>:last-child>:last-child{margin-bottom:0!important}.content article>:last-child>:last-child>:last-child{margin-bottom:0!important}.content article>:last-child>:last-child>:last-child>:last-child{margin-bottom:0!important}.content .page-content>:first-child,.content .post-content>:first-child{margin-top:0}.content .page-content>:first-child>:first-child,.content .post-content>:first-child>:first-child{margin-top:0}.content a{font-weight:700}.content a:has(>code){-webkit-text-decoration-color:var(--code-color);text-decoration-color:var(--code-color)}.content p{margin-bottom:1.6rem;line-height:calc(var(--line-height) * 1.2)}.content header{--header-height:100vh;--space-header:var(--space-lg);display:-webkit-box;display:flex;min-height:calc(var(--header-height) - (var(--nav-padding) * 4) - (var(--nav-item-space) * 4) - (1ex * .9 * 2));padding-top:10vmin;padding-bottom:10vmin;margin-bottom:16vmin;-webkit-box-orient:vertical;-webkit-box-direction:normal;flex-direction:column;-webkit-box-pack:center;justify-content:center;background:var(--text-color-3);padding-left:var(--space-header);padding-right:var(--space-header);margin-left:calc(var(--space-header) * -1);margin-right:calc(var(--space-header) * -1)}@media (max-width:1080px){.content header{--header-height:70vh;--space-header:var(--space-md);padding-top:16vmin;padding-bottom:16vmin}}@media (max-width:640px){.content header{--space-header:var(--space-sm)}}.content header h1{font-size:360%;font-weight:700;letter-spacing:var(--heading-letter-spacing);margin-left:-2px;-webkit-hyphens:none;-ms-hyphens:none;hyphens:none;line-height:1.1}@media (max-width:640px){.content header h1{font-size:280%}}.content header h1 img,.content header h1 svg{display:block;max-width:100%;margin-left:0;margin-right:0;margin-bottom:.3em}@media (max-width:640px){.content header h1 img,.content header h1 svg{width:100%!important;height:100%!important}}.content header h2{margin:1.2vmin 0 0}.content header .image-title{text-indent:-999999px;line-height:0}.content header small{display:block;margin-top:2vmin}.content h2,.content h3,.content h4,.content h5,.content h6{margin:10vmin 0 1rem;font-size:72%;font-weight:400;opacity:.5}.content ol,.content ul{margin-bottom:1.8rem;list-style:none;counter-reset:list}@media (max-width:640px){.content ol,.content ul{margin-left:1em}}.content ol li,.content ul li{line-height:calc(var(--line-height) * 1.2)}.content ol li::before,.content ul li::before{position:absolute;display:-webkit-box;display:flex;-webkit-box-pack:end;justify-content:flex-end;width:4em;margin-top:0;margin-left:-4em;text-align:right;opacity:.4;pointer-events:none}.content ol li>ol,.content ol li>ul,.content ul li>ol,.content ul li>ul{margin-left:1em;margin-bottom:0}.content ul li::before{content:"-";padding-right:.5em}.content ol li::before{counter-increment:list;content:counter(list) ".";padding-right:.25em}.content dl{line-height:calc(var(--line-height) * 1.2)}@media (max-width:640px){.content dl{margin-left:1em}}.content dl dt::before{position:absolute;width:1em;margin-left:-1em;content:"-";opacity:.6;pointer-events:none}.content dl dd{margin-bottom:1.8rem}.content .browser,.content iframe,.content img,.content video{--space-deco:var(--space-md);display:block;width:calc(100% + var(--space-deco) * 2);margin-left:calc(var(--space-deco) * -1);margin-right:calc(var(--space-deco) * -1);margin-bottom:1.8rem}@media (max-width:1080px){.content .browser,.content iframe,.content img,.content video{--space-deco:var(--space-md)}}@media (max-width:640px){.content .browser,.content iframe,.content img,.content video{--space-deco:var(--space-sm)}}.content .browser.no-enlarge,.content .browser.size-fit,.content iframe.no-enlarge,.content iframe.size-fit,.content img.no-enlarge,.content img.size-fit,.content video.no-enlarge,.content video.size-fit{margin-left:0;margin-right:0;max-width:100%;width:auto}.content .browser.size-large,.content iframe.size-large,.content img.size-large,.content video.size-large{--space-deco:var(--space-lg)}@media (max-width:1080px){.content .browser.size-large,.content iframe.size-large,.content img.size-large,.content video.size-large{--space-deco:var(--space-md)}}@media (max-width:640px){.content .browser.size-large,.content iframe.size-large,.content img.size-large,.content video.size-large{--space-deco:var(--space-sm)}}.content .browser.size-small,.content iframe.size-small,.content img.size-small,.content video.size-small{--space-deco:var(--space-xs)}@media (max-width:1080px){.content .browser.size-small,.content iframe.size-small,.content img.size-small,.content video.size-small{--space-deco:var(--space-md)}}@media (max-width:640px){.content .browser.size-small,.content iframe.size-small,.content img.size-small,.content video.size-small{--space-deco:var(--space-sm)}}.content .browser.size-left,.content iframe.size-left,.content img.size-left,.content video.size-left{float:left;max-width:36vw;margin-top:calc(var(--space-xs)/ 2);margin-right:var(--space-xs);margin-bottom:calc(var(--space-xs)/ 2)}@media (max-width:1080px){.content .browser.size-left,.content iframe.size-left,.content img.size-left,.content video.size-left{float:none;max-width:none;margin-top:auto;margin-right:auto;margin-bottom:auto}}.content .browser.size-right,.content iframe.size-right,.content img.size-right,.content video.size-right{float:right;max-width:36vw;margin-top:calc(var(--space-xs)/ 2);margin-left:var(--space-xs);margin-bottom:calc(var(--space-xs)/ 2)}@media (max-width:1080px){.content .browser.size-right,.content iframe.size-right,.content img.size-right,.content video.size-right{float:none;max-width:none;margin-top:auto;margin-left:auto;margin-bottom:auto}}.content .browser.no-resize,.content .browser.noresize,.content .browser.size-original,.content iframe.no-resize,.content iframe.noresize,.content iframe.size-original,.content img.no-resize,.content img.noresize,.content img.size-original,.content video.no-resize,.content video.noresize,.content video.size-original{width:unset;max-width:100%;margin-left:unset;margin-right:unset}.content .browser.no-resize.center,.content .browser.noresize.center,.content .browser.size-original.center,.content iframe.no-resize.center,.content iframe.noresize.center,.content iframe.size-original.center,.content img.no-resize.center,.content img.noresize.center,.content img.size-original.center,.content video.no-resize.center,.content video.noresize.center,.content video.size-original.center{margin-left:auto;margin-right:auto}.content blockquote{position:relative;margin-bottom:2.8rem;margin-left:calc(var(--space-xs) * -1);font-size:90%}@media (max-width:640px){.content blockquote{margin-left:0}}.content blockquote>p{padding-left:var(--space-xs);border-left:var(--border-md) solid;padding-bottom:1.6em;margin-bottom:0;opacity:.6}.content blockquote>p:last-of-type{padding-bottom:0;margin-bottom:.4em}@media (max-width:640px){.content blockquote>p{padding-left:calc(var(--space-sm) - var(--border-md));padding-right:var(--space-sm);margin-left:calc(var(--space-sm) * -1);margin-right:calc(var(--space-sm) * -1)}}.content blockquote footer::after,.content blockquote footer::before{display:table;content:""}.content blockquote footer::after{clear:both}.content blockquote cite{float:right;font-style:normal}.content blockquote cite::before{content:"\2500\2500\00a0"}.content details{margin-bottom:1.8rem}.content details summary{position:relative;list-style:none;line-height:calc(var(--line-height) * 1.2);outline:0;cursor:pointer}@media (max-width:640px){.content details summary{margin-left:1em}}.content details summary::-webkit-details-marker{display:none}.content details summary::before{content:"+";position:absolute;display:-webkit-box;display:flex;-webkit-box-pack:center;justify-content:center;width:1ex;left:-.5em;margin-top:0;margin-left:-1ex;text-align:right;opacity:.4;-webkit-transition:opacity .2s ease,-webkit-transform .2s ease;transition:opacity .2s ease,-webkit-transform .2s ease;transition:opacity .2s ease,transform .2s ease;transition:opacity .2s ease,transform .2s ease,-webkit-transform .2s ease;-webkit-transform-origin:center center;transform-origin:center center;font-feature-settings:"case"}.content details[open] summary::before{opacity:1;-webkit-transform:rotate(45deg);transform:rotate(45deg)}.content hr::before{display:block;content:'';width:3px;height:3px;margin:2em auto;border-radius:50%;background:var(--text-color);box-shadow:24px 0 0 0 var(--text-color),-24px 0 0 0 var(--text-color)}.content sup{font-size:75%}.content code,.content pre{font-family:var(--fontstack-monospace);color:var(--code-color)}.content pre{background:var(--code-color-5)}.content code{font-size:92%;overflow-wrap:break-word}.content .highlight>pre,.content .highlighter-rouge pre.highlight,.content pre{--space-code:var(--space-xs);padding-top:var(--space-xs);padding-bottom:var(--space-xs);padding-left:var(--space-code);padding-right:var(--space-code);margin-left:calc(var(--space-code) * -1);margin-right:calc(var(--space-code) * -1);margin-bottom:1.8rem;overflow-x:auto;font-size:80%;line-height:calc(var(--line-height) * 1.2);-webkit-overflow-scrolling:touch}@media (max-width:1080px){.content .highlight>pre,.content .highlighter-rouge pre.highlight,.content pre{--space-code:var(--space-md)}}@media (max-width:640px){.content .highlight>pre,.content .highlighter-rouge pre.highlight,.content pre{--space-code:var(--space-sm)}}.content .highlight>pre code,.content .highlighter-rouge pre.highlight code,.content pre code{overflow-wrap:normal}.content form input{display:block;width:100%;padding:1vmin 0;margin:0 0 1.8rem;border:none;border-bottom:1px solid var(--text-color);background:inherit;border-radius:0;outline:0;-webkit-transition:padding .2s ease;transition:padding .2s ease}.content form input:focus{border-color:var(--text-color)}.content input:focus:required:invalid:focus,.content select:focus:required:invalid:focus,.content textarea:focus:required:invalid:focus{color:var(--link-color);border-color:var(--link-color);box-shadow:none}.content table{--space-table:var(--space-xs);border-collapse:collapse;border-spacing:0;font-size:90%;width:100%;margin-left:calc(var(--space-table) * -1);margin-right:calc(var(--space-table) * -1);margin-bottom:1.8rem}@media (max-width:1080px){.content table{--space-table:var(--space-md);width:calc(100% + var(--space-table) * 2)}}@media (max-width:640px){.content table{--space-table:var(--space-sm);width:calc(100% + var(--space-table) * 2)}}.content table td,.content table th{--space-table-cell:var(--space-xs);padding:.6em var(--space-xs)}.content table td:first-child,.content table th:first-child{padding-left:var(--space-table-cell)}.content table td:last-child,.content table th:last-child{padding-right:var(--space-table-cell)}@media (max-width:1080px){.content table td,.content table th{--space-table-cell:var(--space-md)}}@media (max-width:640px){.content table td,.content table th{--space-table-cell:var(--space-sm)}}.content table th{border-bottom:var(--border-md) solid var(--text-color-5);text-align:left}.content table td{border-top:var(--border-sm) solid var(--text-color-5)}:lang(ja),:lang(zh){text-align:justify}:lang(ja) header,:lang(ja) header *,:lang(zh) header,:lang(zh) header *{text-align:start}:lang(ja) ruby rt,:lang(zh) ruby rt{text-align:start}.post-modified-date{font-size:75%;opacity:.5}.largetype{font-size:360%;font-weight:700;letter-spacing:var(--heading-letter-spacing);font-size:200%;margin-bottom:1.8rem!important}.browser{position:relative;padding-top:24px;background:rgba(255,255,255,.1);border-radius:5px 5px 0 0;box-shadow:0 0 0 1px rgba(0,0,0,.05)}@media (max-width:1080px),(max-width:640px){.browser{border-radius:0}}.browser::before{position:absolute;top:8px;left:10px;display:block;width:8px;height:8px;background:#fcdddf;border-radius:50%;content:"";box-shadow:16px 0 0 0 rgba(254,240,203,.96),32px 0 0 0 rgba(177,247,185,.96),0 0 0 1px rgba(156,11,21,.3),16px 0 0 1px rgba(147,108,4,.3),32px 0 0 1px rgba(11,107,22,.3)}.browser img{margin-left:0;margin-right:0;width:auto;max-width:100%;box-shadow:0 -1px 0 0 rgba(0,0,0,.05)}.screenshot-mac{--osx-shadow-size:56px;margin-left:calc(var(--osx-shadow-size) * -1);margin-right:calc(var(--osx-shadow-size) * -1)}@media (max-width:1080px),(max-width:640px){.screenshot-mac{margin-left:0;margin-right:0}}.download,.note,.store{padding-left:var(--space-xs);margin-left:calc(var(--space-xs) * -1);border-left:var(--border-md) solid var(--link-color)}@media (max-width:640px){.download,.note,.store{padding-left:calc(var(--space-sm) - var(--border-md));padding-right:var(--space-sm);margin-left:calc(var(--space-sm) * -1);margin-right:calc(var(--space-sm) * -1)}}.footnotes{font-size:80%}.footnotes::before{display:block;content:'';width:3px;height:3px;margin:2em auto;border-radius:50%;background:var(--text-color);box-shadow:24px 0 0 0 var(--text-color),-24px 0 0 0 var(--text-color)}:target .footnote,:target .reversefootnote,:target [rel=footnote],:target [rev=footnote]{color:var(--link-color)}.list{display:block;margin:0 0 .4rem}.list h1{font-size:360%;font-weight:700;letter-spacing:var(--heading-letter-spacing);font-size:200%;line-height:1.1;opacity:1;margin:0}@media (max-width:640px){.list h1{font-size:180%}}@media (max-width:640px){.list .external{display:none}}.external .dot{display:inline-block;width:.7rem;height:.7rem;margin:0 .1em;vertical-align:middle;background:var(--text-color);border-radius:50%;-webkit-transition:-webkit-transform .4s ease;transition:-webkit-transform .4s ease;transition:transform .4s ease;transition:transform .4s ease,-webkit-transform .4s ease}.external .dot--post{margin-left:1rem}.external:focus .dot,.external:hover .dot{-webkit-transform:scale(1.4);transform:scale(1.4)}.of-case{font-feature-settings:"case"}.footer{padding:0 0 16vmin;margin-right:calc(var(--nav-item-space) * -1);margin-left:calc(var(--nav-item-space) * -1);font-size:80%;text-transform:lowercase}.footer ul li{display:inline-block;line-height:1.8}.footer ul li a{padding:.5em var(--nav-item-space)}.gist{font-size:80%!important}.gist code,.gist pre{padding:0;color:inherit;background-color:transparent}.gist .gist-data{font-family:var(--fontstack-monospace)!important}.gist .gist-data .file-data{font-size:100%!important}.gist .gist-data .file-data>table{margin-bottom:0!important}.gist .highlight{font-size:90%!important}.gist .markdown-body{font-size:100%!important;padding:1em!important}@media print{*,::after,::before{background:0 0!important;color:#000!important;box-shadow:none!important;text-shadow:none!important}body{padding:10mm!important;margin:0!important;font-size:calc(var(--font-size) * 1.35)}a,a:visited{text-decoration:none}.content header{min-height:0;padding-bottom:0}.content .page-content,.content .post-content{max-width:100%!important}.content .page-content a[href]::after,.content .post-content a[href]::after{content:" (" attr(href) ")";font-weight:400;opacity:.5}.content .page-content a[href^="#"]::after,.content .page-content a[href^="javascript:"]::after,.content .post-content a[href^="#"]::after,.content .post-content a[href^="javascript:"]::after{content:""}.content .page-content abbr[title]::after,.content .post-content abbr[title]::after{content:" (" attr(title) ")";font-weight:400}blockquote,pre{page-break-inside:avoid}thead{display:table-header-group}img,tr{page-break-inside:avoid}img{max-width:100%!important}h2,h3,h4,h5,h6,p{orphans:3;widows:3}h2,h3{page-break-after:avoid}.footer,.navigation{display:none}}:root{--rdmz-h:var(--code-color-h, 253.962264151);--rdmz-s:var(--code-color-s, 79.8994974874%);--rdmz-l:var(--code-color-l, 39.0196078431%)}.highlight>pre,.highlighter-rouge pre.highlight{background:hsla(var(--rdmz-h),var(--rdmz-s),var(--rdmz-l),.03)}.highlight .err,.highlighter-rouge .err{background-color:hsla(var(--rdmz-h),calc(var(--rdmz-s) * 2),var(--rdmz-l),.1)}.highlight .c,.highlighter-rouge .c{font-style:italic}.highlight .cm,.highlighter-rouge .cm{font-style:italic}.highlight .cp,.highlighter-rouge .cp{font-weight:700}.highlight .c1,.highlighter-rouge .c1{font-style:italic}.highlight .cs,.highlighter-rouge .cs{font-weight:700;font-style:italic}.highlight .nc,.highlighter-rouge .nc{font-weight:700}.highlight .ne,.highlighter-rouge .ne{font-weight:700}.highlight .nf,.highlighter-rouge .nf{font-weight:700}.highlight .o,.highlighter-rouge .o{font-weight:700}.highlight .ow,.highlighter-rouge .ow{font-weight:700}.highlight .gs,.highlighter-rouge .gs{font-weight:700}.highlight .ge,.highlighter-rouge .ge{font-style:italic}.highlight .k,.highlighter-rouge .k{font-weight:700}.highlight .kt,.highlighter-rouge .kt{font-weight:700}.highlight .kc,.highlighter-rouge .kc{font-weight:700}.highlight .kd,.highlighter-rouge .kd{font-weight:700}.highlight .kp,.highlighter-rouge .kp{font-weight:700}.highlight .kr,.highlighter-rouge .kr{font-weight:700}.highlight code,.highlight pre,.highlighter-rouge code,.highlighter-rouge pre{--rdmz-h-local:var(--rdmz-h);color:hsl(var(--rdmz-h),var(--rdmz-s),var(--rdmz-l))}.highlight .err,.highlighter-rouge .err{--rdmz-h-local:calc(var(--rdmz-h) + 5.3731343284);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .x,.highlighter-rouge .x{--rdmz-h-local:calc(var(--rdmz-h) + 10.7462686567);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .n,.highlighter-rouge .n{--rdmz-h-local:calc(var(--rdmz-h) + 16.1194029851);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .na,.highlighter-rouge .na{--rdmz-h-local:calc(var(--rdmz-h) + 21.4925373134);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .nb,.highlighter-rouge .nb{--rdmz-h-local:calc(var(--rdmz-h) + 26.8656716418);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .bp,.highlighter-rouge .bp{--rdmz-h-local:calc(var(--rdmz-h) + 32.2388059701);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .nc,.highlighter-rouge .nc{--rdmz-h-local:calc(var(--rdmz-h) + 37.6119402985);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .no,.highlighter-rouge .no{--rdmz-h-local:calc(var(--rdmz-h) + 42.9850746269);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .nd,.highlighter-rouge .nd{--rdmz-h-local:calc(var(--rdmz-h) + 48.3582089552);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .ni,.highlighter-rouge .ni{--rdmz-h-local:calc(var(--rdmz-h) + 53.7313432836);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .ne,.highlighter-rouge .ne{--rdmz-h-local:calc(var(--rdmz-h) + 59.1044776119);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .nf,.highlighter-rouge .nf{--rdmz-h-local:calc(var(--rdmz-h) + 64.4776119403);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .nl,.highlighter-rouge .nl{--rdmz-h-local:calc(var(--rdmz-h) + 69.8507462687);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .nn,.highlighter-rouge .nn{--rdmz-h-local:calc(var(--rdmz-h) + 75.223880597);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .nx,.highlighter-rouge .nx{--rdmz-h-local:calc(var(--rdmz-h) + 80.5970149254);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .nt,.highlighter-rouge .nt{--rdmz-h-local:calc(var(--rdmz-h) + 85.9701492537);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .nv,.highlighter-rouge .nv{--rdmz-h-local:calc(var(--rdmz-h) + 91.3432835821);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .vc,.highlighter-rouge .vc{--rdmz-h-local:calc(var(--rdmz-h) + 96.7164179104);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .vg,.highlighter-rouge .vg{--rdmz-h-local:calc(var(--rdmz-h) + 102.089552239);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .vi,.highlighter-rouge .vi{--rdmz-h-local:calc(var(--rdmz-h) + 107.462686567);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .g,.highlighter-rouge .g{--rdmz-h-local:calc(var(--rdmz-h) + 112.835820896);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .gd,.highlighter-rouge .gd{--rdmz-h-local:calc(var(--rdmz-h) + 118.208955224);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .ge,.highlighter-rouge .ge{--rdmz-h-local:calc(var(--rdmz-h) + 123.582089552);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .gr,.highlighter-rouge .gr{--rdmz-h-local:calc(var(--rdmz-h) + 128.955223881);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .gh,.highlighter-rouge .gh{--rdmz-h-local:calc(var(--rdmz-h) + 134.328358209);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .gi,.highlighter-rouge .gi{--rdmz-h-local:calc(var(--rdmz-h) + 139.701492537);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .go,.highlighter-rouge .go{--rdmz-h-local:calc(var(--rdmz-h) + 145.074626866);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .gp,.highlighter-rouge .gp{--rdmz-h-local:calc(var(--rdmz-h) + 150.447761194);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .gs,.highlighter-rouge .gs{--rdmz-h-local:calc(var(--rdmz-h) + 155.820895522);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .gu,.highlighter-rouge .gu{--rdmz-h-local:calc(var(--rdmz-h) + 161.194029851);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .gt,.highlighter-rouge .gt{--rdmz-h-local:calc(var(--rdmz-h) + 166.567164179);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .gl,.highlighter-rouge .gl{--rdmz-h-local:calc(var(--rdmz-h) + 171.940298507);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .k,.highlighter-rouge .k{--rdmz-h-local:calc(var(--rdmz-h) + 177.313432836);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .kc,.highlighter-rouge .kc{--rdmz-h-local:calc(var(--rdmz-h) + 182.686567164);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .kd,.highlighter-rouge .kd{--rdmz-h-local:calc(var(--rdmz-h) + 188.059701493);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .kn,.highlighter-rouge .kn{--rdmz-h-local:calc(var(--rdmz-h) + 193.432835821);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .kp,.highlighter-rouge .kp{--rdmz-h-local:calc(var(--rdmz-h) + 198.805970149);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .kr,.highlighter-rouge .kr{--rdmz-h-local:calc(var(--rdmz-h) + 204.179104478);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .kt,.highlighter-rouge .kt{--rdmz-h-local:calc(var(--rdmz-h) + 209.552238806);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .kv,.highlighter-rouge .kv{--rdmz-h-local:calc(var(--rdmz-h) + 214.925373134);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .w,.highlighter-rouge .w{--rdmz-h-local:calc(var(--rdmz-h) + 220.298507463);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .l,.highlighter-rouge .l{--rdmz-h-local:calc(var(--rdmz-h) + 225.671641791);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .ld,.highlighter-rouge .ld{--rdmz-h-local:calc(var(--rdmz-h) + 231.044776119);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .s,.highlighter-rouge .s{--rdmz-h-local:calc(var(--rdmz-h) + 236.417910448);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .sb,.highlighter-rouge .sb{--rdmz-h-local:calc(var(--rdmz-h) + 241.791044776);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .sc,.highlighter-rouge .sc{--rdmz-h-local:calc(var(--rdmz-h) + 247.164179104);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .sd,.highlighter-rouge .sd{--rdmz-h-local:calc(var(--rdmz-h) + 252.537313433);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .s2,.highlighter-rouge .s2{--rdmz-h-local:calc(var(--rdmz-h) + 257.910447761);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .se,.highlighter-rouge .se{--rdmz-h-local:calc(var(--rdmz-h) + 263.28358209);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .sh,.highlighter-rouge .sh{--rdmz-h-local:calc(var(--rdmz-h) + 268.656716418);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .si,.highlighter-rouge .si{--rdmz-h-local:calc(var(--rdmz-h) + 274.029850746);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .sx,.highlighter-rouge .sx{--rdmz-h-local:calc(var(--rdmz-h) + 279.402985075);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .sr,.highlighter-rouge .sr{--rdmz-h-local:calc(var(--rdmz-h) + 284.776119403);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .s1,.highlighter-rouge .s1{--rdmz-h-local:calc(var(--rdmz-h) + 290.149253731);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .ss,.highlighter-rouge .ss{--rdmz-h-local:calc(var(--rdmz-h) + 295.52238806);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .m,.highlighter-rouge .m{--rdmz-h-local:calc(var(--rdmz-h) + 300.895522388);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .mf,.highlighter-rouge .mf{--rdmz-h-local:calc(var(--rdmz-h) + 306.268656716);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .mh,.highlighter-rouge .mh{--rdmz-h-local:calc(var(--rdmz-h) + 311.641791045);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .mi,.highlighter-rouge .mi{--rdmz-h-local:calc(var(--rdmz-h) + 317.014925373);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .il,.highlighter-rouge .il{--rdmz-h-local:calc(var(--rdmz-h) + 322.388059701);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .mo,.highlighter-rouge .mo{--rdmz-h-local:calc(var(--rdmz-h) + 327.76119403);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .mb,.highlighter-rouge .mb{--rdmz-h-local:calc(var(--rdmz-h) + 333.134328358);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .mx,.highlighter-rouge .mx{--rdmz-h-local:calc(var(--rdmz-h) + 338.507462687);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .o,.highlighter-rouge .o{--rdmz-h-local:calc(var(--rdmz-h) + 343.880597015);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .ow,.highlighter-rouge .ow{--rdmz-h-local:calc(var(--rdmz-h) + 349.253731343);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .p,.highlighter-rouge .p{--rdmz-h-local:calc(var(--rdmz-h) + 354.626865672);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .pi,.highlighter-rouge .pi{--rdmz-h-local:calc(var(--rdmz-h) + 360);color:hsl(var(--rdmz-h-local),var(--rdmz-s),var(--rdmz-l))}.highlight .gd,.highlighter-rouge .gd{--rdmz-h-local:10}.highlight .gi,.highlighter-rouge .gi{--rdmz-h-local:150}.highlight .c,.highlighter-rouge .c{color:hsla(calc(var(--rdmz-h) + 5.3731343284),calc(var(--rdmz-s) * .7),var(--rdmz-l),.6)}.highlight .cd,.highlighter-rouge .cd{color:hsla(calc(var(--rdmz-h) + 10.7462686567),calc(var(--rdmz-s) * .7),var(--rdmz-l),.6)}.highlight .cm,.highlighter-rouge .cm{color:hsla(calc(var(--rdmz-h) + 16.1194029851),calc(var(--rdmz-s) * .7),var(--rdmz-l),.6)}.highlight .cp,.highlighter-rouge .cp{color:hsla(calc(var(--rdmz-h) + 21.4925373134),calc(var(--rdmz-s) * .7),var(--rdmz-l),.6)}.highlight .c1,.highlighter-rouge .c1{color:hsla(calc(var(--rdmz-h) + 26.8656716418),calc(var(--rdmz-s) * .7),var(--rdmz-l),.6)}.highlight .cs,.highlighter-rouge .cs{color:hsla(calc(var(--rdmz-h) + 32.2388059701),calc(var(--rdmz-s) * .7),var(--rdmz-l),.6)}.highlight table,.highlight table td,.highlight table td pre,.highlight table th,.highlighter-rouge table,.highlighter-rouge table td,.highlighter-rouge table td pre,.highlighter-rouge table th{padding:0;margin:0;border:none;background:0 0;font-size:100%}.highlight table pre,.highlighter-rouge table pre{overflow-x:visible}.highlight table .gutter:first-child,.highlight table .gutter:last-child,.highlighter-rouge table .gutter:first-child,.highlighter-rouge table .gutter:last-child{padding:0!important}.highlight table .gutter .lineno,.highlighter-rouge table .gutter .lineno{color:hsla(var(--rdmz-h),calc(var(--rdmz-s) * .4),var(--rdmz-l),.4);-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none}.highlight table .code,.highlighter-rouge table .code{padding-left:1em}body,html{max-width:100%;overflow-x:hidden}body{height:100%;width:100%;margin:0}.content{margin-bottom:0}.content h2,.content h3,.content h4,.content h5,.content h6{opacity:1;margin:0}.content ul li::before{content:"\2022"}.content hr::before{margin:0 auto;height:0;width:0}.essay,.essay-equiv{margin:0 auto}.essay .press-comment-wrapper,.essay-equiv .press-comment-wrapper{margin-left:.9em}.content a,.navigation,a,blockquote,figcaption,ol li,p,span,ul li{font-weight:var(--reg-w)}#fi{font-weight:var(--sem-w)!important}.bottom-research-wrapper .bghead,.bottom-research-wrapper .head,.bottom-research-wrapper .rubric,.bottom-research-wrapper .title,.bottom-research-wrapper .title a,.bottom-research-wrapper h2,.bottom-research-wrapper h2 a,.bottom-research-wrapper h3,.bottom-research-wrapper strong,.digest-form-wrapper .bghead,.digest-form-wrapper .head,.digest-form-wrapper .rubric,.digest-form-wrapper .title,.digest-form-wrapper .title a,.digest-form-wrapper h2,.digest-form-wrapper h2 a,.digest-form-wrapper h3,.digest-form-wrapper strong,.essay .bghead,.essay .head,.essay .rubric,.essay .title,.essay .title a,.essay h2,.essay h2 a,.essay h3,.essay strong,.essay-equiv .bghead,.essay-equiv .head,.essay-equiv .rubric,.essay-equiv .title,.essay-equiv .title a,.essay-equiv h2,.essay-equiv h2 a,.essay-equiv h3,.essay-equiv strong,.gallery .bghead,.gallery .head,.gallery .rubric,.gallery .title,.gallery .title a,.gallery h2,.gallery h2 a,.gallery h3,.gallery strong,.hero .bghead,.hero .head,.hero .rubric,.hero .title,.hero .title a,.hero h2,.hero h2 a,.hero h3,.hero strong{font-weight:var(--sem-w)!important}.bottom-research-wrapper .bgcta,.bottom-research-wrapper .bgcta a,.bottom-research-wrapper .cta,.bottom-research-wrapper .cta a,.bottom-research-wrapper .essay-nav,.bottom-research-wrapper .subhead,.bottom-research-wrapper figure figcaption,.digest-form-wrapper .bgcta,.digest-form-wrapper .bgcta a,.digest-form-wrapper .cta,.digest-form-wrapper .cta a,.digest-form-wrapper .essay-nav,.digest-form-wrapper .subhead,.digest-form-wrapper figure figcaption,.essay .bgcta,.essay .bgcta a,.essay .cta,.essay .cta a,.essay .essay-nav,.essay .subhead,.essay figure figcaption,.essay-equiv .bgcta,.essay-equiv .bgcta a,.essay-equiv .cta,.essay-equiv .cta a,.essay-equiv .essay-nav,.essay-equiv .subhead,.essay-equiv figure figcaption,.gallery .bgcta,.gallery .bgcta a,.gallery .cta,.gallery .cta a,.gallery .essay-nav,.gallery .subhead,.gallery figure figcaption,.hero .bgcta,.hero .bgcta a,.hero .cta,.hero .cta a,.hero .essay-nav,.hero .subhead,.hero figure figcaption{font-weight:var(--reg-w)!important}.essay .qst,.essay .subheading{font-weight:var(--med-w)}a{color:var(--m-blue)}a:focus::-webkit-input-placeholder{color:var(--m-blue)}a:focus::-moz-placeholder{color:var(--m-blue)}a:focus:-ms-input-placeholder{color:var(--m-blue)}a:focus::-ms-input-placeholder{color:var(--m-blue)}.navigation,a{letter-spacing:var(--txt-ls)}.bottom-research-wrapper .title,.bottom-research-wrapper .title a,.bottom-research-wrapper h2,.digest-form-wrapper .title,.digest-form-wrapper .title a,.digest-form-wrapper h2,.essay .title,.essay .title a,.essay h2,.essay-equiv .title,.essay-equiv .title a,.essay-equiv h2,.gallery .title,.gallery .title a,.gallery h2,.hero .title,.hero .title a,.hero h2{letter-spacing:var(--met-ls)}.bottom-research-wrapper .bghead,.bottom-research-wrapper .head,.bottom-research-wrapper h3,.digest-form-wrapper .bghead,.digest-form-wrapper .head,.digest-form-wrapper h3,.essay .bghead,.essay .head,.essay h3,.essay-equiv .bghead,.essay-equiv .head,.essay-equiv h3,.gallery .bghead,.gallery .head,.gallery h3,.hero .bghead,.hero .head,.hero h3{letter-spacing:var(--hed-ls)}.bottom-research-wrapper .bgcta,.bottom-research-wrapper .cta,.bottom-research-wrapper .cta a,.bottom-research-wrapper .deck,.bottom-research-wrapper .essay-nav,.bottom-research-wrapper .subhead,.bottom-research-wrapper blockquote,.bottom-research-wrapper ol li,.bottom-research-wrapper p,.bottom-research-wrapper ul li,.digest-form-wrapper .bgcta,.digest-form-wrapper .cta,.digest-form-wrapper .cta a,.digest-form-wrapper .deck,.digest-form-wrapper .essay-nav,.digest-form-wrapper .subhead,.digest-form-wrapper blockquote,.digest-form-wrapper ol li,.digest-form-wrapper p,.digest-form-wrapper ul li,.essay .bgcta,.essay .cta,.essay .cta a,.essay .deck,.essay .essay-nav,.essay .subhead,.essay blockquote,.essay ol li,.essay p,.essay ul li,.essay-equiv .bgcta,.essay-equiv .cta,.essay-equiv .cta a,.essay-equiv .deck,.essay-equiv .essay-nav,.essay-equiv .subhead,.essay-equiv blockquote,.essay-equiv ol li,.essay-equiv p,.essay-equiv ul li,.gallery .bgcta,.gallery .cta,.gallery .cta a,.gallery .deck,.gallery .essay-nav,.gallery .subhead,.gallery blockquote,.gallery ol li,.gallery p,.gallery ul li,.hero .bgcta,.hero .cta,.hero .cta a,.hero .deck,.hero .essay-nav,.hero .subhead,.hero blockquote,.hero ol li,.hero p,.hero ul li{letter-spacing:var(--txt-ls)}#fi{letter-spacing:var(--hed-ls)}.essay-equiv .press-comment .title{letter-spacing:var(--txt-ls)}.essay figure .credits{font-size:95%}blockquote{font-size:100%!important}.bottom-research-wrapper .rubric,.digest-form-wrapper .rubric,.essay .rubric,.essay-equiv .rubric,.gallery .rubric,.hero .rubric{color:var(--m-accent)}.bottom-research-wrapper .title,.bottom-research-wrapper .title a,.digest-form-wrapper .title,.digest-form-wrapper .title a,.essay .title,.essay .title a,.essay-equiv .title,.essay-equiv .title a,.gallery .title,.gallery .title a,.hero .title,.hero .title a{color:var(--xm-silver)}.bottom-research-wrapper .head,.bottom-research-wrapper strong,.digest-form-wrapper .head,.digest-form-wrapper strong,.essay .head,.essay strong,.essay-equiv .head,.essay-equiv strong,.gallery .head,.gallery strong,.hero .head,.hero strong{color:var(--x-black)}.bottom-research-wrapper .cta,.digest-form-wrapper .cta,.essay .cta,.essay-equiv .cta,.gallery .cta,.hero .cta{color:var(--m-blue)}.bottom-research-wrapper blockquote,.bottom-research-wrapper ol li,.bottom-research-wrapper p,.bottom-research-wrapper ul li,.digest-form-wrapper blockquote,.digest-form-wrapper ol li,.digest-form-wrapper p,.digest-form-wrapper ul li,.essay blockquote,.essay ol li,.essay p,.essay ul li,.essay-equiv blockquote,.essay-equiv ol li,.essay-equiv p,.essay-equiv ul li,.gallery blockquote,.gallery ol li,.gallery p,.gallery ul li,.hero blockquote,.hero ol li,.hero p,.hero ul li{color:var(--xm-black)}.essay figure figcaption{color:var(--m-gray)}.essay figure .credits{color:var(--x-silver)}.essay-nav ul li{line-height:var(--xxw-lh)}.digest-form-wrapper .head,.essay .head,.gallery .head,.hero .head{line-height:var(--xn-lh)}.digest-form-wrapper .deck,.digest-form-wrapper blockquote,.digest-form-wrapper ol li,.digest-form-wrapper p,.digest-form-wrapper ul li,.essay .deck,.essay blockquote,.essay ol li,.essay p,.essay ul li,.gallery .deck,.gallery blockquote,.gallery ol li,.gallery p,.gallery ul li,.hero .deck,.hero blockquote,.hero ol li,.hero p,.hero ul li{line-height:var(--wd-lh)}.digest-form-wrapper .footnotes p,.essay .footnotes p,.gallery .footnotes p,.hero .footnotes p{line-height:var(--xw-lh)}.bottom-research .gallery-feature .deck,.gallery-unit .deck{line-height:var(--nr-lh)}.digest-form-wrapper .title,.digest-form-wrapper title a,.essay .title,.essay title a,.gallery .title,.gallery title a,.hero .title,.hero title a{text-decoration:none}.digest-form-wrapper .rubric,.essay .rubric,.gallery .rubric,.hero .rubric{text-transform:uppercase}.digest-form-wrapper ol li,.digest-form-wrapper ul li,.essay ol li,.essay ul li,.gallery ol li,.gallery ul li,.hero ol li,.hero ul li{margin-bottom:.3em}.digest-form-wrapper hr,.essay hr,.gallery hr,.hero hr{padding:0 0 8vw}.bottom-research,.callout,.essay-nav,.footer,.gallery,.navigation,.new,figure figcaption{text-align:center}.txt-wrap{white-space:nowrap}.navigation{margin:var(--nil) var(--full-wid);background-color:var(--x-black);padding:0}.navigation li{padding:.5em 0}.navigation li a{color:var(--xx-white)}.navigation .current a,.navigation li a:focus,.navigation li a:hover{color:var(--xm-silver)!important}.navigation #logomark a svg{width:1.2em;height:1.2em;margin-bottom:-.15rem}.cta-arrow{height:.6em;width:.6em;display:inline-block;position:relative}.rot-down{left:2px}.rot-right{left:4px;-webkit-transform:rotate(-90deg);transform:rotate(-90deg)}.rot-up{-webkit-transform:rotate(180deg);transform:rotate(180deg)}.fill-blue{fill:#03549b}.fill-slvr{fill:#898989}.back-to-top-arrow{height:.7em;width:.7em;display:inline-block}.fn-ext-lnk{margin-left:.15em}header.hero{margin:0;text-align:center;background-color:var(--background-color)}.hero{margin:auto!important}.hero .title{margin-bottom:.2rem!important}.hero .title a{color:var(--xm-silver);text-decoration:none}.hero .bghead,.hero .head{line-height:var(--xn-lh);color:var(--x-black)}.hero .subhead{padding:.4em 0 .3em;margin:0 auto 0!important;line-height:var(--wd-lh)!important}.hero .bgcta,.hero .cta{margin:0;padding:0}.hero .bgcta a,.hero .cta a{color:var(--m-blue)!important;padding-right:.2rem}.hero .po-aro{color:var(--m-blue)}.hero img{margin:1em auto 0}.essay-nav{font-size:82%;margin:var(--nil) var(--full-wid) -5vh;padding:0;z-index:1;border-bottom:1px solid var(--x-silver)}.essay-nav ul{margin-bottom:0}.essay-nav ul li{display:inline-block;padding:.5em 0}.essay-nav ul li:before{display:none}.essay-nav a.sticky-btn{font-weight:var(--reg-w);padding:.3em 1em;margin:0 1em;color:var(--l-black);text-decoration:none;-webkit-transition:none;transition:none}.essay-nav a.sticky-btn:hover{opacity:.7}.essay{counter-reset:count-fn 0 count-qst 0}.essay .comments-wrapper{counter-increment:count-com;margin-left:5%;max-width:91%;padding-top:9vh;margin-top:-9vh}.essay .comments-wrapper:first-of-type .comments-nav .prev-com{visibility:hidden}.essay .comments-wrapper:last-of-type .comments-nav .next-com{visibility:hidden}.essay .comments-wrapper summary{font-weight:500;font-size:120%;color:#03549b}.essay .comments-wrapper summary::before{opacity:1}.essay .comments-wrapper summary::after{content:" " counter(count-com)}.essay .comments-wrapper .comments{font-size:91%;background-color:#f9f8ca;border-radius:20px;padding:2em .7em 1em 0;margin-top:1.6em;margin-bottom:1.6em}.essay .comments-wrapper .comments a{text-decoration:underline}.essay .comments-wrapper .comments blockquote{font-size:125%!important;color:#555;border-left:#aaa 4px solid;padding-left:.5em;margin-bottom:1.4em}.essay .comments-wrapper .comments blockquote strong{font-weight:500!important}.essay .comments-wrapper .comments .comments-nav a{position:relative;color:#999;text-decoration:none}.essay .comments-wrapper .comments .comments-nav a:hover{text-decoration:underline}.essay .comments-wrapper .comments .comments-nav .prev-com{left:5%}.essay .comments-wrapper .comments .comments-nav .next-com{left:71%}.essay .essay-header{padding:8vw 0}.essay .callout .rubric{margin:0 auto -1.5em;position:relative;top:-1.5em}.essay .callout .title{margin:0}.essay .callout .head{margin:0 0 .3em}.essay .callout .deck{margin:0 auto}.essay .callout .byline{display:none}.essay .callout .cta{margin:0;padding-top:.7rem}.essay .callout .cta a{padding-right:.2rem;padding-bottom:.2em;margin-left:1%}.essay .callout .po-aro{position:relative;top:-.2em;left:.2em}.essay .section-headings{position:relative;padding-top:8vw!important}.essay .section-headings .title a{text-decoration:none;padding:8vw 0 0}.essay .section-headings .head{max-width:65%;font-variant-ligatures:no-common-ligatures}.essay figure figcaption{padding-top:.5rem;margin:auto}.essay figure .credits-blk{display:block}.essay figure .credits-inl{display:inline}.essay .qst{margin-top:-3em;padding-top:4.2em}.essay .qst::before{color:var(--m-gray);counter-increment:count-qst;content:counter(count-qst) ".";position:absolute;display:-webkit-box;display:flex;-webkit-box-pack:end;justify-content:flex-end;width:4em;margin-top:0;margin-left:-4em;text-align:right;opacity:.4;pointer-events:none;padding-right:.25em}.essay .qst-lnk{padding:.2em .3em!important;margin-right:-1.5em}.essay .qst-lnk svg{fill:var(--m-gray);opacity:.4;vertical-align:middle}.essay .qst-lnk:hover svg{fill:var(--xm-black);opacity:1}.essay blockquote p{opacity:1!important;border-color:var(--m-silver)}.essay .notice{background-color:var(--vl-accent);border-radius:20px;padding:.5em 0 1.2em;margin:3.5em auto 0}.essay .notice h4{text-align:center;margin:2em auto}.essay .notice h4 a{color:var(--m-blue);font-weight:var(--sem-w);text-decoration:none;text-transform:uppercase;letter-spacing:.025em;padding:25vh 0 0}.essay .notice p{text-align:center}.essay .notice ul.contact-list{text-align:center;line-height:var(--wd-lh);color:var(--m-gray);letter-spacing:var(--txt-ls)}.essay .notice ul.contact-list li{display:block;margin:0 auto .3em}.essay .notice ul.contact-list li:before{content:" "!important;display:none}.essay .notice ul.contact-list li a:hover{color:var(--x-black);-webkit-transition:none;transition:none}.essay .notice .cta{color:var(--m-blue)}.essay .notice .cta span{position:relative;bottom:1.5px}.essay .fn-btn{background-color:var(--l-silver);position:relative;margin-left:.3em;color:var(--m-gray);font-weight:var(--sem-w);font-size:90%;text-decoration:none}.essay .fn-btn:hover{background-color:var(--xl-silver)}.essay .fn-btn:focus{outline:0}.essay .fn-btn-top{padding:.25em 1em .35em!important;top:.35em;margin-left:.2em}.essay .fn-btn-bot{padding:.35em .8em .3em!important;margin-left:.5em;top:.1em}.essay sup{padding-top:25vh;margin-top:-25vh}.essay .footnotes{font-size:inherit;padding-bottom:2.2vw;border-top:1px solid var(--m-silver);padding-top:2em}.essay .footnotes:before{display:none}.essay .footnotes ol li{display:-webkit-box;display:flex}.essay .footnotes ol li:before{color:var(--m-gray);position:relative;display:inline-block;counter-increment:count-fn;content:counter(count-fn) "."}.essay #img-cap-com-abt-1{display:none!important}.essay .section-syllabus-ol{margin-top:2em}.essay .section-syllabus-li{border-bottom:1px solid #ddd;padding:.4em 0 .6em 0;line-height:1.3}.essay .section-syllabus-li:first-of-type{padding-top:none}.essay .section-syllabus-li:last-of-type{border-bottom:none}.essay .syllabus-txttitle{font-weight:600}.essay .syllabus-assignment{color:#666}.essay .syllabus-assignment-pages{font-size:80%;color:#666!important;float:right;margin-top:.3em;margin-right:1.2em}.essay .syllabus-edition{color:#2e4b54;font-size:65%;text-transform:uppercase;font-weight:600}.essay .syllabus-elective{font-size:65%;text-transform:uppercase;font-weight:600;color:#005200;float:right;position:relative;top:.4em;right:1.6em}.essay .icon-download{height:17px;top:2px;position:relative;margin-left:3px;fill:#03549b}.essay .icon-external-lnk{height:12px;margin-left:3px;fill:#03549b}.essay .icon-fn-external-lnk{height:9px;margin-left:3px;fill:#03549b}.essay .replay-btn-wrapper{text-align:center;margin-top:.8em}.essay .replay-btn-text{color:#03549b;font-size:110%}.essay .replay-btn-icon{display:inline-block;width:10px;margin-left:.3rem;fill:#03549b}.essay-equiv .press-comment-wrapper{padding-top:2em;padding-bottom:2em;border-top:1px solid var(--m-silver);border-bottom:1px solid var(--m-silver);margin-top:0}.essay-equiv .press-comment-wrapper .press-comment{text-align:left}.essay-equiv .press-comment-wrapper .press-comment .title{color:var(--xm-silver)}.essay-equiv .press-comment-wrapper .press-comment .col-aro,.essay-equiv .press-comment-wrapper .press-comment .cta{color:var(--xxx-silver)}.essay-equiv .press-comment-wrapper .press-comment .po-aro{position:relative;top:-.1em;left:.1em}.essay-equiv .press-comment-wrapper .press-comment .press{margin-top:1.6em}.essay-equiv .bottom-research-wrapper{padding-top:4em;padding-bottom:4em;border-bottom:1px solid var(--m-silver)}.essay-equiv .bottom-research-wrapper .bottom-research .deck{margin:.5em 0}.essay-equiv .bottom-research-wrapper .bottom-research .po-aro{position:relative;top:-.1em;left:.2em}.essay-equiv .digest-form-wrapper{margin:8vw auto}.essay-equiv .digest-form-wrapper .digest-form-header{margin-bottom:12vw;text-align:center}.essay-equiv .digest-form-wrapper .digest-form-header .title{margin-bottom:0}.essay-equiv .digest-form-wrapper .digest-form-header .head{margin-bottom:.3em}.gallery-digest{max-width:58%;margin:-5em auto 0}.gallery-digest .digest-form-wrapper{margin:8vw auto}.gallery-digest .digest-form-wrapper .digest-form-header{margin-bottom:12vw;text-align:center}.gallery-digest .digest-form-wrapper .digest-form-header .title{margin-bottom:0}.gallery-digest .digest-form-wrapper .digest-form-header .head{margin-bottom:.3em}.gallery-digest #mc_embed_signup{max-width:100%}#mc_embed_signup{max-width:70%;margin:8vw auto 0;font-size:120%!important;font-weight:400!important;letter-spacing:var(--txt-ls)}#mc_embed_signup form{padding:0!important}#mc_embed_signup .mc-field-group{padding-bottom:0!important}#mc_embed_signup .mc-field-group label{font-size:110%;color:var(--m-gray);margin-bottom:.3em!important}#mc_embed_signup .mc-field-group input{display:block;width:100%;padding:1vmin 0;margin:.3em 0 1.8rem;border:none;border-bottom:1px solid var(--xm-silver);border-radius:0;outline:0;-webkit-transition:padding .2s ease;transition:padding .2s ease}#mc_embed_signup .mc-field-group input:focus::-webkit-input-placeholder{color:var(--text-color)!important}#mc_embed_signup .mc-field-group input:focus::-moz-placeholder{color:var(--text-color)!important}#mc_embed_signup .mc-field-group input:focus:-ms-input-placeholder{color:var(--text-color)!important}#mc_embed_signup .mc-field-group input:focus::-ms-input-placeholder{color:var(--text-color)!important}#mc_embed_signup .mc-field-group input:focus::placeholder{color:var(--text-color)!important}#mc_embed_signup .mc-field-group input:focus{border-bottom:2px solid var(--xm-black)}#mc_embed_signup #mc-embedded-subscribe-form input.mce_inline_error{border:none!important;border-bottom:1px solid var(--xm-silver)!important;border-radius:0}#mc_embed_signup #mc-embedded-subscribe-form input.mce_inline_error:focus{border-bottom:2px solid var(--xm-black)!important}#mc_embed_signup .clear{text-align:center}#mc_embed_signup .button{text-align:left;background-color:transparent!important;padding:0!important;margin:0!important;border:none!important;vertical-align:baseline!important;color:var(--m-blue)!important;letter-spacing:var(--txt-ls);display:inline-block;width:initial}#mc_embed_signup .button:hover{text-decoration:underline}#mc_embed_signup .po-aro{position:relative!important;top:-.1em;left:.2em}#mc_embed_signup div#mce-responses{margin:0!important;padding:0!important}#mc_embed_signup div.response{padding:0 0 .6em 0!important;margin:0;width:100%;font-weight:400!important;font-size:90%!important;color:var(--l-black)!important;text-align:center}#mc_embed_signup div.response a{color:var(--m-blue)!important;display:block}#mc_embed_signup #mce-success-response{color:#0b701b!important}#mc_embed_signup div.mce_inline_error{display:none!important}.email-octopus-form-wrapper{margin:8vw auto 0;font-size:120%!important;font-weight:400!important;letter-spacing:var(--txt-ls);text-align:center}.email-octopus-form-wrapper .email-octopus-success-message{color:green}.email-octopus-form-wrapper .email-octopus-error-message{color:#d00000}.email-octopus-form-wrapper .email-octopus-form-row-hp{position:absolute;left:-5000px}.email-octopus-form-wrapper .email-octopus-form .email-octopus-form-row{margin:0 auto;max-width:100%;text-align:left}.email-octopus-form-wrapper .email-octopus-form .email-octopus-form-row label{font-size:110%;color:var(--m-gray);margin-bottom:.6em!important}.email-octopus-form-wrapper .email-octopus-form .email-octopus-form-row input{display:block;max-width:100%;padding:1vmin 0;margin:.3em 0 1.8rem;border:none;border-bottom:1px solid var(--xm-silver);border-radius:0;outline:0;-webkit-transition:padding .2s ease;transition:padding .2s ease}.email-octopus-form-wrapper .email-octopus-form .email-octopus-form-row input:focus::-webkit-input-placeholder{color:var(--text-color)!important}.email-octopus-form-wrapper .email-octopus-form .email-octopus-form-row input:focus::-moz-placeholder{color:var(--text-color)!important}.email-octopus-form-wrapper .email-octopus-form .email-octopus-form-row input:focus:-ms-input-placeholder{color:var(--text-color)!important}.email-octopus-form-wrapper .email-octopus-form .email-octopus-form-row input:focus::-ms-input-placeholder{color:var(--text-color)!important}.email-octopus-form-wrapper .email-octopus-form .email-octopus-form-row input:focus::placeholder{color:var(--text-color)!important}.email-octopus-form-wrapper .email-octopus-form .email-octopus-form-row input:focus{border-bottom:2px solid var(--xm-black)}.email-octopus-form-wrapper .email-octopus-form .email-octopus-form-row-subscribe button{text-align:left;background-color:transparent!important;padding:0!important;margin:0!important;border:none!important;vertical-align:baseline!important;color:var(--m-blue)!important;letter-spacing:var(--txt-ls);font-weight:var(--reg-w);display:inline-block;width:initial}.email-octopus-form-wrapper .email-octopus-form .email-octopus-form-row-subscribe button:hover{text-decoration:underline}.email-octopus-form-wrapper .email-octopus-form .email-octopus-form-row-subscribe .po-aro{position:relative!important;top:-.1em;left:.2em}.gallery .gallery-feature-wrapper,.gallery .gallery-unit-wrapper{border-bottom:1px solid var(--l-silver)}.gallery .gallery-feature .head,.gallery .gallery-unit .head{margin-bottom:.3em}.gallery .gallery-feature .deck,.gallery .gallery-unit .deck{margin:0 auto;margin-bottom:.6em}.gallery .gallery-feature .po-aro,.gallery .gallery-unit .po-aro{position:relative;top:-.1em;left:.2em}.gallery .gallery-feature{margin:6em auto}.gallery .gallery-feature .deck{max-width:45%}.gallery .gallery-grid{display:grid;gap:0;grid-template-columns:repeat(2,1fr);width:100%}.gallery .gallery-unit-wrapper{display:-webkit-box;display:flex;-webkit-box-orient:vertical;-webkit-box-direction:normal;flex-direction:column;margin:0}.gallery .gallery-unit-wrapper:nth-child(odd){border-right:1px solid var(--l-silver)}.gallery .gallery-unit{margin:6em 0}.gallery .gallery-unit .deck{max-width:65%}.footer a,.footer p{margin:0 .2em;padding:0 .1em!important}.footer a,.footer p,.footer ul{display:inline-block;text-transform:capitalize}.footer ul li:before{content:" "!important;display:none}.footer .return-top{text-align:center;margin-bottom:6vh}.footer .return-top a{font-size:130%;text-decoration:none;padding:.15em .7em .3em!important;border-radius:7px;margin-left:.2em}.footer .return-top a:hover{text-decoration:none}.footer-light{padding:0;margin:4vh auto 3vh}.footer-light a,.footer-light p{color:var(--xxx-silver)}.footer-light .return-top a{background-color:var(--l-silver)}.footer-light .return-top a:hover{background-color:var(--xl-silver)}.footer-hide,.hr-hide{display:none}:root{--reg-w:400;--med-w:500;--sem-w:600;--hed-ls:-.065em;--met-ls:-.04em;--txt-ls:-.025em;--xn-lh:1;--nr-lh:1.2;--wd-lh:1.35;--vw-lh:1.4;--xw-lh:1.5;--xxw-lh:2;--lg-rubric:70%;--lg-title:210%;--lg-head:395%;--lg-deck:140%;--lg-cta:130%;--lg-bghead:440%;--lg-subhead:160%;--lg-bgcta:150%;--md-rubric:80%;--md-title:240%;--md-head:450%;--md-deck:160%;--md-cta:150%;--md-bghead:450%;--md-subhead:180%;--md-bgcta:170%;--sm-rubric:90%;--sm-title:230%;--sm-head:370%;--sm-deck:180%;--sm-cta:170%;--sm-bghead:430%;--sm-subhead:200%;--sm-bgcta:180%;--xs-rubric:65%;--xs-title:170%;--xs-head:280%;--xs-deck:130%;--xs-cta:130%;--xs-bghead:330%;--xs-subhead:155%;--xs-bgcta:140%;--lg-nav:90%;--md-nav:120%;--sm-nav:140%;--xs-nav:110%;--lg-txt:130%;--md-txt:150%;--sm-txt:170%;--xs-txt:130%;--lg-fn:100%;--mo-fn:80%;--lg-fig:90%;--md-fig:115%;--sm-fig:130%;--xs-fig:95%;--lg-not:110%;--md-not:140%;--sm-not:160%;--xs-not:120%;--lg-foo:80%;--md-foo:105%;--sm-foo:120%;--xs-foo:90%;--xx-black:#0d0d0d;--x-black:#111;--xm-black:#222;--m-black:#272727;--l-black:#333;--xl-black:#444;--m-gray:#555;--m-blue:#03549b;--xx-white:#fff;--xxx-silver:#898989;--xx-silver:#aaa;--x-silver:#bbb;--xm-silver:#cfcfcf;--m-silver:#ddd;--l-silver:#eee;--xl-silver:#e7e7e7;--m-accent:#805e03;--vl-accent:#f6f6f6;--nil:0;--full-wid:-50%;--space-lg:21vw}@font-face{font-family:Barlow;font-style:normal;font-weight:400;src:local("Barlow Regular"),local("Barlow-Regular"),url(https://fonts.gstatic.com/s/barlow/v4/7cHpv4kjgoGqM7E_DMs5ynghnQ.woff2) format("woff2");unicode-range:U+0000-00FF,U+0131,U+0152-0153,U+02BB-02BC,U+02C6,U+02DA,U+02DC,U+2000-206F,U+2074,U+20AC,U+2122,U+2191,U+2193,U+2212,U+2215,U+FEFF,U+FFFD}@font-face{font-family:Barlow;font-style:italic;font-weight:400;src:local("Barlow Italic"),local("Barlow-Italic"),url(https://fonts.gstatic.com/s/barlow/v4/7cHrv4kjgoGqM7E_Cfs7wH8Dnzcj.woff2) format("woff2");unicode-range:U+0000-007F}@font-face{font-family:Barlow;font-style:normal;font-weight:500;src:local("Barlow Medium"),local("Barlow-Medium"),url(https://fonts.gstatic.com/s/barlow/v4/7cHqv4kjgoGqM7E3_-gs51ostz0rdg.woff2) format("woff2");unicode-range:U+0000-007F}@font-face{font-family:Barlow;font-style:normal;font-weight:600;src:local("Barlow SemiBold"),local("Barlow-SemiBold"),url(https://fonts.gstatic.com/s/barlow/v4/7cHqv4kjgoGqM7E30-8s51ostz0rdg.woff2) format("woff2");unicode-range:U+0000-00FF,U+0131,U+0152-0153,U+02BB-02BC,U+02C6,U+02DA,U+02DC,U+2000-206F,U+2074,U+20AC,U+2122,U+2191,U+2193,U+2212,U+2215,U+FEFF,U+FFFD}@font-face{font-family:system-ui;font-style:normal;font-weight:400;src:local(".SFNSText-Regular"),local(".HelveticaNeueDeskInterface-Regular"),local(".LucidaGrandeUI"),local("Segoe UI"),local("Ubuntu"),local("Roboto-Regular"),local("DroidSans"),local("Tahoma")}@font-face{font-family:system-ui;font-style:normal;font-weight:600;src:local(".SFNSText-Medium"),local(".HelveticaNeueDeskInterface-MediumP4"),local(".LucidaGrandeUI"),local("Segoe UI Semibold"),local("Ubuntu Medium"),local("Roboto-Medium"),local("DroidSans-Bold"),local("Tahoma Bold")}:root{--font-size:1.3vw;--fontstack-prefix:'Barlow','Barlow-Local',system-ui;--fontstack-sans-serif:'Barlow','Barlow-Local',system-ui,sans-serif}html{font-family:Barlow,Barlow-Local,system-ui,sans-serif}@media screen and (max-width:799px){.essay .footnotes ol li::before,.essay .footnotes p{font-size:var(--mo-fn)}.essay,.essay-equiv{max-width:100%}.essay blockquote,.essay p,.essay-equiv blockquote,.essay-equiv p{max-width:94%;margin-left:3%}.essay ol,.essay ul,.essay-equiv ol,.essay-equiv ul{max-width:97%;margin-left:0!important}.essay ol li,.essay ul li,.essay-equiv ol li,.essay-equiv ul li{margin-left:1.5em}.navigation li{padding:.6em .3em;margin:0 .5em 0 0}.cta-arrow{height:.5em;width:.55em}header.hero{padding:25% 0 5%}.hero h2{margin:.2rem auto 0!important}.hero img{width:75%}.essay-nav{display:none}.essay blockquote,.essay ol li,.essay p,.essay ul li{line-height:var(--vw-lh)}.essay blockquote,.essay ol,.essay p,.essay ul{margin-bottom:1.2em}.essay .callout{margin:0 auto 6vw!important;padding:15% 0 20%}.essay .section-headings{margin-bottom:8vw;left:3%;max-width:100%}.essay figure{margin:11% auto 10%}.essay figure img{width:110%;margin-bottom:0}.essay figure figcaption{max-width:95%}.essay .qst{margin-top:-1.3em;padding-top:2em}.essay .qst::before{margin-left:0;margin-right:.6em;font-weight:var(--sem-w);width:1em;-webkit-box-pack:center;justify-content:center;text-align:center;padding-right:0;position:unset;display:inline-block}.essay .notice{margin:3.5em -50% 0}.essay .notice p{max-width:52%;margin:0 auto 1.2em}.essay .notice ul.contact-list{max-width:100%;margin:0 auto 1em}.essay .fn-btn{border-radius:4px}.essay .footnotes{margin-top:10vw}.essay .footnotes p{margin-left:0;max-width:90%}.essay .footnotes ol li{margin-left:0;padding-top:11vh;margin-top:-11vh}.essay .footnotes ol li:before{margin-top:.05em;margin-left:-2.3em}.essay #deck-com-abt{max-width:100%}.essay #deck-res-int-scannell{max-width:100%}.essay #img-cap-res-int-scannell-1{max-width:85%}.gallery-digest{max-width:83%}.gallery .gallery-grid{grid-template-columns:none}.gallery .gallery-feature,.gallery .gallery-unit{margin:4em 0}.gallery .gallery-feature .deck{max-width:90%}.gallery .gallery-unit .deck{max-width:95%}.bottom-toc{max-width:100%;margin-left:0}.footer ul{margin-left:0}.email-octopus-form-row{margin:20vw auto 0!important}#mc_embed_signup{max-width:90%;margin:20vw auto 0;font-size:150%!important}#mc_embed_signup div.response{width:80%;margin:0 auto}}@media screen and (max-width:400px){.navigation{font-size:var(--xs-nav)}.hero .bghead{font-size:var(--xs-bghead)}.hero .subhead{font-size:var(--xs-subhead)}.hero .bgcta{font-size:var(--xs-bgcta)}.bottom-research-wrapper .rubric,.digest-form-wrapper .rubric,.essay .rubric,.essay-equiv .rubric,.gallery .rubric,.hero .rubric{font-size:var(--xs-rubric)}.bottom-research-wrapper .title,.bottom-research-wrapper h2,.digest-form-wrapper .title,.digest-form-wrapper h2,.essay .title,.essay h2,.essay-equiv .title,.essay-equiv h2,.gallery .title,.gallery h2,.hero .title,.hero h2{font-size:var(--xs-title)!important}.bottom-research-wrapper .head,.bottom-research-wrapper h3,.digest-form-wrapper .head,.digest-form-wrapper h3,.essay .head,.essay h3,.essay-equiv .head,.essay-equiv h3,.gallery .head,.gallery h3,.hero .head,.hero h3{font-size:var(--xs-head)}.bottom-research-wrapper .deck,.digest-form-wrapper .deck,.essay .deck,.essay-equiv .deck,.gallery .deck,.hero .deck{font-size:var(--xs-deck)}.bottom-research-wrapper .cta,.digest-form-wrapper .cta,.essay .cta,.essay-equiv .cta,.gallery .cta,.hero .cta{font-size:var(--xs-cta)}.essay ol li,.essay p,.essay ul li{font-size:var(--xs-txt)}.essay figure{font-size:var(--xs-fig)}.essay .notice h4 a{font-size:var(--xs-not)}.essay blockquote p{font-size:calc(var(--xs-txt) * .9)!important}.essay-equiv .press-comment .cta{font-size:calc(var(--lg-fn))!important}.essay-equiv .press-comment .title{font-size:calc(var(--lg-fn) * 1.2)!important}.footer{font-size:var(--xs-foo)}.essay blockquote p{margin:auto 0;max-width:100%}.essay #deck-com-mis{max-width:91%}.essay #img-cap-com-mis-2{max-width:76%}.essay-equiv .press-comment-wrapper{margin-left:0}.essay-equiv .press-comment{margin-left:.9em}.essay-equiv .bottom-research .deck{margin:.5em auto!important;line-height:1.2;max-width:55%}.essay-equiv .digest-form-wrapper{margin:16vw auto}.essay-equiv .digest-form-wrapper .digest-form-header{margin-bottom:12vw}.essay-equiv .digest-form-wrapper .digest-form-header .deck{max-width:55%;margin:0 auto;line-height:var(--nr-lh)}.essay-equiv .digest-form-wrapper .digest-form-header .deck span{display:inline-block}.essay-equiv #mc_embed_signup{font-size:120%!important}.gallery-digest{margin:8vw auto 12vw}.gallery-digest #mc_embed_signup{font-size:120%!important}.gallery-digest .digest-form-wrapper .digest-form-header .deck span{display:inline-block}}@media screen and (min-width:401px) and (max-width:639px){.navigation{font-size:var(--sm-nav)}.hero .bghead{font-size:var(--sm-bghead)}.hero .subhead{font-size:var(--sm-subhead)}.hero .bgcta{font-size:var(--sm-bgcta)}.bottom-research-wrapper .rubric,.digest-form-wrapper .rubric,.essay .rubric,.gallery .rubric,.hero .rubric{font-size:var(--sm-rubric)}.bottom-research-wrapper .title,.bottom-research-wrapper h2,.digest-form-wrapper .title,.digest-form-wrapper h2,.essay .title,.essay h2,.gallery .title,.gallery h2,.hero .title,.hero h2{font-size:var(--sm-title)!important}.bottom-research-wrapper .head,.bottom-research-wrapper h3,.digest-form-wrapper .head,.digest-form-wrapper h3,.essay .head,.essay h3,.gallery .head,.gallery h3,.hero .head,.hero h3{font-size:var(--sm-head)!important}.bottom-research-wrapper .deck,.digest-form-wrapper .deck,.essay .deck,.gallery .deck,.hero .deck{font-size:var(--sm-deck)!important}.bottom-research-wrapper .cta,.digest-form-wrapper .cta,.essay .cta,.gallery .cta,.hero .cta{font-size:var(--sm-cta)}.essay-equiv .press-comment-wrapper{margin-left:0}.essay-equiv .press-comment{margin-left:.9em}.essay ol li,.essay p,.essay ul li{font-size:var(--sm-txt)}.essay figure{font-size:var(--sm-fig)}.essay .notice h4 a{font-size:var(--sm-not)}.essay blockquote p{font-size:calc(var(--sm-txt) * .9)!important}.essay-equiv .press-comment .cta{font-size:calc(var(--lg-fn) * 1.4)!important}.essay-equiv .press-comment .title{font-size:calc(var(--lg-fn) * 1.6)!important}.footer{font-size:var(--sm-foo)}.essay blockquote p{margin:auto 0;max-width:100%}.essay #deck-com-mis{max-width:95%}.essay #img-cap-com-mis-2{max-width:80%}.essay-equiv .bottom-research .deck{margin:.5em auto!important;line-height:1.2;max-width:55%}.essay-equiv .digest-form-wrapper{margin:16vw auto}.essay-equiv .digest-form-wrapper .digest-form-header{margin-bottom:12vw}.essay-equiv .digest-form-wrapper .digest-form-header .deck{max-width:55%;margin:0 auto;line-height:var(--nr-lh)}.essay-equiv .digest-form-wrapper .digest-form-header .deck span{display:inline-block}.essay-equiv #mc_embed_signup .button{font-size:110%!important}.gallery-digest{margin:8vw auto 12vw}.gallery-digest .email-octopus-form-row{font-size:125%}.gallery-digest .email-octopus-form-row-subscribe button{font-size:135%}.gallery-digest #mc_embed_signup .button{font-size:110%!important}.gallery-digest .digest-form-wrapper .digest-form-header .deck span{display:inline-block}}@media screen and (min-width:640px) and (max-width:799px){.navigation{font-size:var(--md-nav)}.hero .bghead{font-size:var(--md-bghead)}.hero .subhead{font-size:var(--md-subhead)}.hero .bgcta{font-size:var(--md-bgcta)}.bottom-research-wrapper .rubric,.digest-form-wrapper .rubric,.essay .rubric,.gallery .rubric,.hero .rubric{font-size:var(--md-rubric)}.bottom-research-wrapper .title,.bottom-research-wrapper h2,.digest-form-wrapper .title,.digest-form-wrapper h2,.essay .title,.essay h2,.gallery .title,.gallery h2,.hero .title,.hero h2{font-size:var(--md-title)!important}.bottom-research-wrapper .head,.bottom-research-wrapper h3,.digest-form-wrapper .head,.digest-form-wrapper h3,.essay .head,.essay h3,.gallery .head,.gallery h3,.hero .head,.hero h3{font-size:var(--md-head)}.bottom-research-wrapper .deck,.digest-form-wrapper .deck,.essay .deck,.gallery .deck,.hero .deck{font-size:var(--md-deck)!important}.bottom-research-wrapper .cta,.digest-form-wrapper .cta,.essay .cta,.gallery .cta,.hero .cta{font-size:var(--md-cta)}.essay ol li,.essay p,.essay ul li{font-size:var(--md-txt);margin-left:0}.essay figure{font-size:var(--md-fig)}.essay .notice h4 a{font-size:var(--md-not)}.essay blockquote p{font-size:calc(var(--md-txt) * .95)!important}.essay-equiv .press-comment-wrapper .cta{font-size:calc(var(--lg-fn) * 1.2)!important}.essay-equiv .press-comment-wrapper .title{font-size:calc(var(--lg-fn) * 1.4)!important}.footer{font-size:var(--md-foo)}.essay,.essay-equiv{max-width:93%}.essay blockquote,.essay p,.essay-equiv blockquote,.essay-equiv p{max-width:100%}.essay ol li,.essay ul li,.essay-equiv ol li,.essay-equiv ul li{margin-left:0}.essay-equiv .press-comment-wrapper{margin-left:0}.navigation li{margin:0 2em 0}.hero .subhead{max-width:75%}.hero img{width:53%}.essay .section-headings{margin-bottom:6vw;left:0}.essay figure img{width:100%;margin:0 auto;border-radius:20px}.essay figure figcaption{max-width:80%}.essay .about-portrait{width:80%}.essay .qst::before{margin-top:0;margin-left:-4em;font-size:100%;font-weight:var(--reg-w);background-color:transparent;width:4em;-webkit-box-pack:end;justify-content:flex-end;text-align:right;padding-right:.25em;position:absolute;display:-webkit-box;display:flex}.essay .notice{margin:3.5em auto 0}.essay .notice p{max-width:80%}.essay .fn-btn{border-radius:4px}.essay .footnotes{margin:10vw auto 0 -1.75em;max-width:100%}.essay .footnotes ol,.essay .footnotes p{max-width:100%;width:100%}.essay .footnotes ol li:before{margin-left:0;width:1.5em}.essay #deck-com-abt{max-width:68%}.essay #deck-com-mis{max-width:65%}.essay #deck-res-int-scannell{max-width:69%}.essay #img-cap-com-mis-1{max-width:85%}.essay #img-cap-com-mis-2{max-width:70%}.essay #img-cap-res-int-scannell-1{max-width:70%}.essay-equiv .digest-form-wrapper{margin:12vw auto}.essay-equiv .press-comment{display:grid;grid-template-columns:repeat(2,1fr);gap:0}.essay-equiv .press-comment .press{margin-top:0!important}.gallery-digest{max-width:58%}.email-octopus-form-wrapper{margin:-8vw auto 0}.email-octopus-form-row{font-size:125%}.email-octopus-form-row-subscribe button{font-size:130%}#mc_embed_signup{max-width:70%;margin:12vw auto 0}#mc_embed_signup div.response{width:100%;margin:0}}@media screen and (min-width:800px){.navigation{font-size:var(--lg-nav)}.hero .bghead{font-size:var(--lg-bghead)}.hero .subhead{font-size:var(--lg-subhead)}.hero .bgcta{font-size:var(--lg-bgcta)}.bottom-research-wrapper .rubric,.digest-form-wrapper .rubric,.essay .rubric,.essay-equiv .rubric,.gallery .rubric,.hero .rubric{font-size:var(--lg-rubric)}.bottom-research-wrapper .title,.bottom-research-wrapper h2,.digest-form-wrapper .title,.digest-form-wrapper h2,.essay .title,.essay h2,.essay-equiv .title,.essay-equiv h2,.gallery .title,.gallery h2,.hero .title,.hero h2{font-size:var(--lg-title)!important}.bottom-research-wrapper .head,.bottom-research-wrapper h3,.digest-form-wrapper .head,.digest-form-wrapper h3,.essay .head,.essay h3,.essay-equiv .head,.essay-equiv h3,.gallery .head,.gallery h3,.hero .head,.hero h3{font-size:var(--lg-head)}.bottom-research-wrapper .deck,.digest-form-wrapper .deck,.essay .deck,.essay-equiv .deck,.gallery .deck,.hero .deck{font-size:var(--lg-deck)!important}.bottom-research-wrapper .cta,.digest-form-wrapper .cta,.essay .cta,.essay-equiv .cta,.gallery .cta,.hero .cta{font-size:var(--lg-cta)}.gallery .gallery-unit .rubric{font-size:calc(var(--lg-rubric) * .9286)!important}.gallery .gallery-unit .title{font-size:calc(var(--lg-title) * .762)!important}.gallery .gallery-unit .head{font-size:calc(var(--lg-head) * .7595)!important}.gallery .gallery-unit .cta{font-size:calc(var(--lg-cta) * .9231)!important}.essay ol li,.essay p,.essay ul li{font-size:var(--lg-txt)}.essay figure{font-size:var(--lg-fig)}.essay .notice h4 a{font-size:var(--lg-not)}.essay .footnotes ol li,.essay .footnotes p{font-size:var(--lg-fn)}.essay blockquote p{font-size:calc(var(--lg-txt) * .9)!important}.essay-equiv .press-comment-wrapper .cta{font-size:var(--lg-fn)!important}.essay-equiv .press-comment-wrapper .title{font-size:calc(var(--lg-fn) * 1.2)!important}.footer{font-size:var(--lg-foo)}.essay,.essay-equiv{max-width:95%}.essay blockquote,.essay ol li,.essay p,.essay ul li,.essay-equiv blockquote,.essay-equiv ol li,.essay-equiv p,.essay-equiv ul li{max-width:86%;margin-left:5%}.essay-equiv .press-comment{margin-left:3%}.essay-equiv .bottom-research-wrapper,.essay-equiv .digest-form-wrapper{margin-left:0}.essay-equiv .digest-form-header .deck{max-width:91%}.navigation li{padding:.5em 0}.navigation li a{padding:.3em 1em;margin:0 2.5em}.navigation #logomark a img{width:1.2em}.new{margin:var(--nil) var(--full-wid) 4em;padding:.3rem 0 0;top:2em}.new a .headline{font-size:75%}header.hero{padding:10% 0 0;--header-height:unset}.hero h2{margin:.2rem auto .3rem!important}.hero .subhead{max-width:66%}.hero img{width:50%}.essay-nav{display:none}.essay .callout{margin:0 auto!important;padding:4% 0 10%}.essay .section-headings{margin-bottom:5vw;left:-1.5em}.essay .section-dark-wrapper figure{width:63%}.essay .section-dark-wrapper figure img{max-width:100%}.essay figure{margin:10% auto 9%}.essay figure img,.essay figure video{max-width:1200px;margin:0 auto;border-radius:20px}.essay figure video{pointer-events:none}.essay figure .ful-img,.essay figure .ful-vid{width:100%}.essay figure .inl-img,.essay figure .inl-vid{width:91%}.essay figure figcaption{max-width:65%}.essay .notice{max-width:90%;margin:3.5em auto 0}.essay .notice p{max-width:74%;margin:0 auto 4%}.essay .fn-btn{border-radius:7px}.essay .footnotes{max-width:100%;margin:8vw auto 0 .9em}.essay .footnotes ol li{padding-top:10vh;margin-top:-10vh;max-width:100%;margin-left:0}.essay .footnotes ol li p{margin-left:0}.essay .footnotes ol li:before{margin-left:-2.75em}.essay #deck-com-abt{max-width:57%}.essay #deck-com-mis{max-width:57%}.essay #deck-res-int-scannell{max-width:60%}.essay #deck-res-int-ingber{max-width:64%}.essay #img-cap-com-mis-2{max-width:60%}.essay #img-cap-res-int-scannell-1{max-width:58%}.essay #img-com-abt-1{width:80%}.essay-equiv .bottom-research .deck{max-width:100%}.essay-equiv .press-comment{display:grid;grid-template-columns:repeat(2,1fr);gap:0}.essay-equiv .press-comment .press{margin-top:0!important}.gallery .gallery-unit .deck{max-width:90%}.gallery #f1{max-width:38%}}@media screen and (min-width:1080px){.essay,.essay-equiv{max-width:93%}.essay blockquote,.essay ol li,.essay p,.essay ul li,.essay-equiv blockquote,.essay-equiv ol li,.essay-equiv p,.essay-equiv ul li{max-width:91%}.essay-equiv .bottom-research-wrapper,.essay-equiv .press-comment{margin-left:3%}.essay-equiv .digest-form-wrapper .digest-form-header{margin-bottom:8vw}.essay-nav{display:block}.essay-nav-scroll{position:fixed!important;width:100%!important;top:0;left:50%;-webkit-transition:background-color .5s cubic-bezier(.28,.11,.32,1);transition:background-color .5s cubic-bezier(.28,.11,.32,1);border-bottom-color:var(--xl-black)!important;background-color:var(--l-black)!important}.essay-btn-scroll{color:var(--xl-silver)!important}.essay figure figcaption{max-width:70%}.essay #deck-com-abt{max-width:61%}.essay #deck-com-mis{max-width:59%}.essay #deck-res-int-scannell{max-width:64%}.essay #deck-res-int-ingber{max-width:64%}.essay #img-cap-res-int-scannell-1{max-width:60%}.essay #img-cap-res-int-ingber-3{max-width:74%}.essay #img-cap-res-int-ingber-4{max-width:75%}.essay #vid-cap-res-int-ingber-1{max-width:61%}.essay #vid-cap-res-int-ingber-3{max-width:68%}.essay #vid-cap-res-int-ingber-4{max-width:62%}.essay #vid-cap-res-int-ingber-5{max-width:64%}.essay #vid-cap-res-int-ingber-7{max-width:68%}.gallery-digest .digest-form-wrapper{margin:4vw auto!important}.gallery-digest .digest-form-header{margin-bottom:6vw!important}.gallery-digest #mc_embed_signup,.gallery-digest .email-octopus-form-row{max-width:70%}}</style> <link href="https://fonts.googleapis.com/css?family=Barlow:400,400i,500,600&amp;display=swap" rel="stylesheet"> <link rel="canonical" href="https://refoundable.com/ingber"> <meta property="og:type" content="article"> <meta property="og:site_name" content="Refoundable"> <meta property="og:title" content="Biology Beyond Barriers - Interview with Don Ingber"> <meta property="og:url" content="https://refoundable.com/ingber"> <meta property="og:description" content="The man who coined Eroom’s law, on the end of an era in drug R&amp;D, the frontier of drug discovery, and COVID-19."> <meta property="og:image" content="https://refoundable.com/assets/img/og-eroom.png"> <meta name="twitter:card" content="summary_large_image"> <meta name="twitter:site" content="@refoundable"> <style data-assets-inline=""></style> </head><body><nav id="top" class="navigation"> <ul> <li id="logomark"> <a href="/"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 200 200"><path d="M85.7 76H45.2V0h75.6c16 0 32.2.3 46.1 9.1a53.5 53.5 0 0122.8 44.7 48.4 48.4 0 01-31.2 46.1L200 200h-46l-36.3-91.7H24L0 78.8h108.9c8.7 0 18.1.8 25.8-3.7a24.2 24.2 0 0010.5-20.5c0-7-4.2-14.7-10.3-18.3-7-4.5-19.2-3.4-27-3.4H85.6v43zm1.4 35v68.1h-42v-68h42z" fill="#FFF" fill-rule="evenodd"></path></svg></a> </li> <li> <a href="/mission">Mission</a> </li> <li> <a href="/research">Research</a> </li> <li> <a href="/about">About</a> </li> </ul> </nav> <main class="content" role="main"> <script>window.onscroll=function(){window.addEventListener("scroll",stickyNav)}</script> <nav id="sticky-nav" class="essay-nav"> <ul> <li><a class="sticky-btn" href="#s1">Introduction</a></li> <li><a class="sticky-btn" href="#s2">Mechanics</a></li> <li><a class="sticky-btn" href="#s3">Simulacra</a></li> <li><a class="sticky-btn" href="#s4">Integration</a></li> </ul> </nav> <article class="essay"> <div class="essay-header"> <div class="callout"> <div class="meta"> <div class="rubric">Interview<time datetime="2020-09-13T00:00:00-07:00">&nbsp;&nbsp;•&nbsp;&nbsp;Sep 13, 2020</time></div> <div class="title">Coordination</div> </div> <h1 class="head">Biology<br>beyond barriers.</h1> <p class="deck" id="deck-res-int-ingber">Don Ingber, the man who invented organs-on-chips, on planned serendipity, coordination, and nanotechnology that works.</p> <div class="byline"> <span>By John Strider</span><span>&nbsp;|&nbsp;</span> <span><time datetime="2020-09-13T00:00:00-07:00">Sep 13, 2020</time></span><span>&nbsp;|&nbsp;</span> <span>Refoundable</span> </div> <div class="cta"><a href="#s1">Introduction</a><svg xmlns="http://www.w3.org/2000/svg" class="cta-arrow fill-blue rot-down" viewBox="0 0 476 267"><defs></defs><path d="M238 209L447 0l29 29-238 238v-1 1L0 29 29 0l209 209z"></path></svg></div> </div> </div>  <div class="section-headings"> <h2 class="title"><a id="s1">Introduction</a></h2> <h3 class="head">TBD</h3> </div> <hr> <div class="section-headings"> <h2 class="title"><a id="s2">Mechanics</a></h2> <h3 class="head">Beyond the<br>selfish gene.</h3> </div> <p class="qst" id="q1">By the early 1970s, biochemistry and genetics by far the dominant paradigm in biology. How did that happen? And what made you see mechanical force as a major factor in biology that was overlooked?<a class="qst-lnk" href="#q1"><svg viewBox="0 0 16 16" version="1.1" width="16" height="16"><path fill-rule="evenodd" d="M4 9h1v1H4c-1.5 0-3-1.69-3-3.5S2.55 3 4 3h4c1.45 0 3 1.69 3 3.5 0 1.41-.91 2.72-2 3.25V8.59c.58-.45 1-1.27 1-2.09C10 5.22 8.98 4 8 4H4c-.98 0-2 1.22-2 2.5S3 9 4 9zm9-3h-1v1h1c1 0 2 1.22 2 2.5S13.98 12 13 12H9c-.98 0-2-1.22-2-2.5 0-.83.42-1.64 1-2.09V6.25c-1.09.53-2 1.84-2 3.25C6 11.31 7.55 13 9 13h4c1.45 0 3-1.69 3-3.5S14.5 6 13 6z"></path></svg></a></p> <p>When I was starting in biology, molecular biology and biophysics were explained in mechanical terms: the physics of molecules; the lock and key of an enzyme and a substrate; the helical shape of DNA, etc. It wasn’t only the chemistry that mattered, but the spatial relationships between different molecules as well.</p> <p>However, as I got to medical and graduate school, cell biology suddenly became about all chemistry and not much else. Mechanics was completely sidelined, which was odd considering that cells hadn’t changed. They were still made up of large numbers of molecules that were physically interconnected, so mechanics had to be a factor.</p> <p>Then, everything changed again when gene cloning arrived. Instead of messing around with individual molecules, now you could look for the genetic sequence that controls the expression of this or that molecule and switch it on or off. This appealed to molecular biologists because it made getting experimental results much easier.</p> <p>Science journals like <em>Cell</em> soon started holding meetings for journalists to explain how biology was being transformed. The world had changed, they said, and genes were now the key to unlock the whole of biology, a perspective remains dominant to this day.</p> <p>Meanwhile, I was gradually coming around to the idea that mechanics were more important than people realized.</p> <p>As a young undergraduate, I had seen the first timelapse movies ever made of a developing embryo, and you could see cells divide and get smaller and smaller, then start pulling on each other and sculpting the organs out of the embryo. Although the cells were following genetic instructions, everything about the process was still deeply physical.</p> <figure> <video class="inl-vid" id="vid-1" height="100%" autoplay="" muted="" src="/assets/video/buf.mp4" data-echo="/assets/video/res-int-ingber-1.mp4" type="video/mp4"></video> <figcaption id="vid-cap-res-int-ingber-1">A zebrafish embryo undergoes cell division and early organ formation in this timelapse, which is similar to those Ingber saw as an undergraduate.&nbsp;<span class="credits credits-blk">Phoebe Grigg</span></figcaption> <div class="replay-btn-wrapper"> <button type="button" class="replay-btn-text" id="replay-btn-1" onclick="replayVideo(&quot;vid-1&quot;)">Replay<svg class="replay-btn-icon" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 50 59"><defs></defs><path fill-rule="evenodd" d="M25.13 15H25a19 19 0 1019 19h6A25 25 0 1125.27 9L20.9 3.96 25.4.02l10.5 12.08-.44.38-10.31 11.45-4.46-4.01L25.13 15z"></path></svg></button> </div> </figure> <p>My second big hint had a more colorful story. One day, I noticed some students on campus who were carrying sculptures made of cardboard that looked exactly like some of the viruses I saw in biology textbooks, and I found out that they all came from one sculpture class taught by Erwin Hauer on three dimensional design.</p> <p>Art classes at Yale back then were notorious for being very tough to get into, especially for a science major, but I managed to get an interview with professor Hauer, and explained why I wanted to take the class. I said that three dimensional design was everywhere in biology, from X to Y, and that piqued the professor’s interest enough to invite me to join his class.</p> <p>In one of those classes, professor Hauer came in and told us to use some wooden sticks and fishing strings we had lying around to build stable structures that hold their shape, but there was a catch: the sticks couldn’t touch. Then, he left.</p> <p>For a while, we were completely lost until one student figured out how to build one of these structures, and the whole class soon caught on. The secret was to use the strings to connect the sticks at opposite ends, so the sticks didn’t touch, and as you did that for more pieces, the strings became stretched, creating enough tension to hold the structure together.</p> <figure> <video class="ful-vid" id="vid-2" height="100%" autoplay="" muted="" src="/assets/video/buf.mp4" data-echo="/assets/video/res-int-ingber-2.mp4" type="video/mp4"></video> <figcaption id="vid-cap-res-int-ingber-2">Ingber and his classmates built structures similar to these seen here, in which wooden struts push out against a network of elastic threads, putting each structure in a state of isometric tension or&nbsp;prestress that stabilizes its shape.&nbsp;<span class="credits credits-inl">Joseph Arnold</span></figcaption> <div class="replay-btn-wrapper"> <button type="button" class="replay-btn-text" id="replay-btn-2" onclick="replayVideo(&quot;vid-2&quot;)">Replay<svg class="replay-btn-icon" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 50 59"><defs></defs><path fill-rule="evenodd" d="M25.13 15H25a19 19 0 1019 19h6A25 25 0 1125.27 9L20.9 3.96 25.4.02l10.5 12.08-.44.38-10.31 11.45-4.46-4.01L25.13 15z"></path></svg></button> </div> </figure> <p>When professor Hauer returned to class that day, he gave us a slide lecture explaining the principle governing the structures we built, and that was when I first learned about “tensegrity,” a stand-in term for “tensional integrity” coined by Buckminster Fuller.</p> <p>During the lecture, the professor also had with him a spherical ball built using the same principle from struts and elastic strings, and he would squash it against a table and it would be completely flat, then as soon as he’d let go, it would bounce up and jump into the air.</p> <p>That same week, on the other side of campus, I was learning how to culture cancer cells, and the first thing to notice when you place cells in a petri dish is that the cells will spread out flat against the surface and anchor themselves in place. So when you need to move them to another dish, you’d first have to add a chemical enzyme that releases the cell anchors from the surface before you can pick them up.</p> <p>I was doing that for the first time fresh out of Hauer’s class. We added the enzyme and I saw the cells that were flat against the surface of the dish instantly round up like an elastic ball, so I said the first thing that came to my mind: “Oh, the tensegrity must have changed!”</p> <figure> <video class="inl-vid" id="vid-3" height="100%" autoplay="" muted="" src="/assets/video/buf.mp4" data-echo="/assets/video/res-int-ingber-3.mp4" type="video/mp4"></video> <figcaption id="vid-cap-res-int-ingber-3">Cells anchor themselves flat against the surface of a petri dish, but when their anchors are released, they quickly round up, suggesting that they're in a state of isometric tension.&nbsp;<span class="credits credits-inl">Don Ingber</span></figcaption> <div class="replay-btn-wrapper"> <button type="button" class="replay-btn-text" id="replay-btn-3" onclick="replayVideo(&quot;vid-3&quot;)">Replay<svg class="replay-btn-icon" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 50 59"><defs></defs><path fill-rule="evenodd" d="M25.13 15H25a19 19 0 1019 19h6A25 25 0 1125.27 9L20.9 3.96 25.4.02l10.5 12.08-.44.38-10.31 11.45-4.46-4.01L25.13 15z"></path></svg></button> </div> </figure> <p>Back then, people still thought of cells as balloons filled with molasses, so what I said sounded like nonsense to the postdoctoral fellow in the lab, and when I explained that I learned about tensegrity in a sculpture class, he told me to never say that word again.</p> <p>However, I was too intrigued to drop the idea, and I started looking for more clues. I read the first papers that came out around that time discussing how cells get their shape, and they described a cytoskeleton, similar to our own skeletal frame, that supports the cell.</p> <p>Over at the art library on campus, I discovered that people in the 1960s talked about structuralism. György Kepes at MIT published an anthology titled <em>Structure in Art and in Science</em>, in which architects like Fuller, but also biologists, chemists, artists, and other specialists all stressed that the answer to a complex problem is never found by looking at the individual components—the sticks and strings—but by seeing how they are arranged and connected, that is to say, how the whole comes <span class="txt-wrap">together.<sup><a href="#fn1" id="r1" class="fn-btn fn-btn-top">1</a></sup></span></p> <p>This idea had profound implications for biology. To take one example, I&nbsp;knew from molecular biophysics that when you change biochemistry, you cause gene expression to change, because the two are connected. Now I began to realize that tensegrity might offer a theory by which to explain how you can cause biochemistry and gene expression to change by changing the mechanical force <span class="txt-wrap">applied.<sup><a href="#fn2" id="r2" class="fn-btn fn-btn-top">2</a></sup></span></p> <p>Finally, I found the history of biology itself suggestive, as I learned that as late as the 1890s, the discipline was referred to as morphomechanics and developmental mechanics, and biologists of the period were able to explain in mechanical terms problems that were eluding genetic reductionists almost a century later.</p> <p>By this point, I was convinced that mechanical factors were as important as chemicals and genes in the regulation of biology. And I tried to show that in my PhD thesis in 1984 and by building a tensegrity model of the cell and nucleus to explain the experimentally verifiable fact that the two are mechanically connected, which is how they’re able to coordinate their <span class="txt-wrap">behaviors.<sup><a href="#fn3" id="r3" class="fn-btn fn-btn-top">3</a></sup></span></p> <p>Most of what I wrote in my thesis is everything I’ve done since, because all the principal questions were clear even then, and with the benefit of hindsight, that was the beginning of the rest of my life.</p> <figure> <img class="ful-img" alt="A graph of Eroom’s law shows that the cost of developing a new drug roughly doubled every nine years from 1950 through the 2010." id="img-res-int-ingber-1" src="/assets/img/buf.png" data-echo="/assets/img/res-int-ingber-1.jpg"> <figcaption id="img-cap-res-int-ingber-1">The tensegrity model of the cell and nucleus built by Don Ingber in the early 1980s to explain his theory on cell mechanics. The model was rebuilt for an exhibition at the Martin-Gropius-Bau Museum in Berlin in 2016.&nbsp;<span class="credits credits-blk">Humboldt-Universität zu Berlin</span></figcaption> </figure> <p class="qst" id="q2">To show how mechanical force affects cell biology, you came up with clever experiments that combined biology and engineering. What led you to take such an interdisciplinary approach?<a class="qst-lnk" href="#q2"><svg viewBox="0 0 16 16" version="1.1" width="16" height="16"><path fill-rule="evenodd" d="M4 9h1v1H4c-1.5 0-3-1.69-3-3.5S2.55 3 4 3h4c1.45 0 3 1.69 3 3.5 0 1.41-.91 2.72-2 3.25V8.59c.58-.45 1-1.27 1-2.09C10 5.22 8.98 4 8 4H4c-.98 0-2 1.22-2 2.5S3 9 4 9zm9-3h-1v1h1c1 0 2 1.22 2 2.5S13.98 12 13 12H9c-.98 0-2-1.22-2-2.5 0-.83.42-1.64 1-2.09V6.25c-1.09.53-2 1.84-2 3.25C6 11.31 7.55 13 9 13h4c1.45 0 3-1.69 3-3.5S14.5 6 13 6z"></path></svg></a></p> <p>I was investigating cell mechanics, but my training was in cell biology and I never had an engineering class in my life, so to get some help I could call on, I began to collaborate with engineers.</p> <p>My initial goal was to apply mechanical force to cell receptors and show that stretching the cell or distorting its shape would cause its behavior to change. Existing methods, like electrophoresis, were inadequate for this purpose, so I had to look for new methods to control the geometry of the cell.</p> <p>The first was to use magnetic beads to pull on the cell receptors, and the engineers helped me find the right nanometer-sized beads to match the scale of the receptors. That experiment showed that pulling on certain receptors called integrins activated signaling pathways on the cell surface and even turned on gene transcription in the <span class="txt-wrap">cell.<sup><a href="#fn4" id="r4" class="fn-btn fn-btn-top">4</a></sup></span> </p> <p>The second method we moved to allowed us to control the entire shape of a cell as it was growing, which led us to the surprise discovery that changing the shape of a cell changed its function and even its <span class="txt-wrap">fate.<sup><a href="#fn5" id="r5" class="fn-btn fn-btn-top">5</a></sup></span></p> <p>For example, when cells had a lot of room to grow, the stretched and divided continuously until they ran out of space, and the more room they had to expand, the higher the divison rate. By contrast, when cells had no room at all grow, they activated a suicide program called apostatis and died.</p> <p>Between these two extremes, when cells had some room to grow, the division rate was moderate and cells began to differentiate, so liver cells made liver proteins, capillary cells formed tubes, and so on. And by harnessing cells in that in-between region, we found a way to engineer small capillary blood vessels in a few hours, which became one of many applications of tissue engineering.</p> <p>The tools we used in this method came out of the chemistry lab of George Whitesides. He had developed a way to make thousands of computer microchips inexpensively, and upon learning about it, I realized that microchip manufacturing offered control over features at the same scale as cells and tissues. So George and I began to collaborate and we published a series of papers <span class="txt-wrap">together.<sup><a href="#fn6" id="r6" class="fn-btn fn-btn-top">6</a></sup></span> </p> <p>Later, George started making chips with tiny hollow channels that liquids could flow through, and those looked like artificial blood vessels to me. They also had the crucial feature that two liquids flowing through the same channel wouldn’t mix thanks to laminar flow, which meant that you could deliver different chemicals to different points on the surface of the chip and grow more than one cell type in close proximity, each with its own <span class="txt-wrap">microenvironment.<sup><a href="#fn7" id="r7" class="fn-btn fn-btn-top">7</a></sup></span></p> <figure> <video class="inl-vid" id="vid-4" height="100%" autoplay="" muted="" src="/assets/video/buf.mp4" data-echo="/assets/video/res-int-ingber-4.mp4" type="video/mp4"></video> <figcaption id="vid-cap-res-int-ingber-4">At scales below 1 millimeter, turbulence is minimal and the flow of fluid particles becomes smooth or laminar, so two fluids simultaneously passing through the same channel don't mix.&nbsp;<span class="credits credits-inl">Saggiomo and Velders</span></figcaption> <div class="replay-btn-wrapper"> <button type="button" class="replay-btn-text" id="replay-btn-4" onclick="replayVideo(&quot;vid-4&quot;)">Replay<svg class="replay-btn-icon" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 50 59"><defs></defs><path fill-rule="evenodd" d="M25.13 15H25a19 19 0 1019 19h6A25 25 0 1125.27 9L20.9 3.96 25.4.02l10.5 12.08-.44.38-10.31 11.45-4.46-4.01L25.13 15z"></path></svg></button> </div> </figure> <p>The microfluidic sytems that George developed turned out to be the key breakthrough I needed to combine all the methods I had used to study cell mechanics, and apply them in new ways.</p> <p>For example, with my team at the Wyss Institute, we brought back the magnetic beads I used years earlier and combined them with strong magnets and microfluidic channels to develop an artificial liver that clears the blood passing through it, like a dialysis machine, from pathogens that cause hospital patients to develop a deadly form of blood poisoning known as <span class="txt-wrap">sepsis.<sup><a href="#fn8" id="r8" class="fn-btn fn-btn-top">8</a></sup></span></p> <figure> <img class="ful-img" alt="A graph of Eroom’s law shows that the cost of developing a new drug roughly doubled every nine years from 1950 through the 2010." id="img-res-int-ingber-2" src="/assets/img/buf.png" data-echo="/assets/img/res-int-ingber-2.jpg"> <figcaption id="img-cap-res-int-ingber-2">Magnetic beads (gray) are attached to an engineered protein called FcMBL that binds to E. coli bacteria (green) and over a hundred other pathogens which cause blood poisoning in hospital patients.&nbsp;<span class="credits credits-blk">Wyss Institute</span></figcaption> </figure> <p>Likewise, by combining microfluidic channels with our insight into cell mechanics and vascular biology, we were able to develop organs-on-chips, a technology being used to test drug toxicity and accelerate drug development.</p> <p>My experience testifies that the more barriers you cross, the more tools, methods, and materials you’ll encounter that are waiting to be combined into your next breakthrough.</p> <p>So I never understand why people focus on making incremental gains in one area when they could be working with people from other disciplines and together making giants leaps in different directions. To me, that’s what real progress looks like.</p> <p class="qst" id="q3">In 1998, you summarized your research over the preceding decade and a half and called out genetic reductionism in a Scientific American titled The Architecture of Life. How were your ideas received?<a class="qst-lnk" href="#q3"><svg viewBox="0 0 16 16" version="1.1" width="16" height="16"><path fill-rule="evenodd" d="M4 9h1v1H4c-1.5 0-3-1.69-3-3.5S2.55 3 4 3h4c1.45 0 3 1.69 3 3.5 0 1.41-.91 2.72-2 3.25V8.59c.58-.45 1-1.27 1-2.09C10 5.22 8.98 4 8 4H4c-.98 0-2 1.22-2 2.5S3 9 4 9zm9-3h-1v1h1c1 0 2 1.22 2 2.5S13.98 12 13 12H9c-.98 0-2-1.22-2-2.5 0-.83.42-1.64 1-2.09V6.25c-1.09.53-2 1.84-2 3.25C6 11.31 7.55 13 9 13h4c1.45 0 3-1.69 3-3.5S14.5 6 13 6z"></path></svg></a></p> <p>I started presenting my research in the mid-1980s, and from the very first moment, I was publicly attacked for it. My tensegrity model of the cell and nucleus was called an art show by senior scientists, “bullshit” was a popular word among my critics, and I&nbsp;was called Darth Vader for promulgating “this force thing.”</p> <p><em>The Biophysical Journal</em> wouldn’t publish any of my papers for 30 years because tensegrity was anathema to the editors. One paper received positive peer reviews recommending to accept it with minor revisions and it was still turned down. When I appealed to the journal saying we could easily make the minor revisions, the editors replied: “At the Biophysical Journal, we allow only one response to the reviewers’ comments, and you just used it.”</p> <p>To this day, the term tensegrity is not used. All the other concepts like prestress and cell shape have become an accepted part of biology, but they will not use that word. I was even told explicitly once by a program manager at the NIH that they would be ready to fund my grant requests if I just took that word out.</p> <p>I never compromised. Early in my career, I had a formative experience working as a postdoc with Judah Folkman and I saw first-hand how he was publicly criticized for his research on tumor angiogenesis in major outlets like <em>Science</em>, <em>Time Magazine</em>, and <em>The Wall Street Journal</em>. I was already resilient, but seeing everything Dr. Folkman endured made me all the more <span class="txt-wrap">determined.<sup><a href="#fn9" id="r9" class="fn-btn fn-btn-top">9</a></sup></span></p> <p>Once, we submitted a paper to <em>Science</em> on the discovery of a fungus-derived drug that inhibited angiogenesis, and sure enough the journal turned it down. To mark the occasion, Judah handed me a book about the discovery of penicillin, another fungi-derived drug, and he turned to a page that showed the letter Alexander Fleming received in 1929 from the editors of <em>Nature</em> dismissing his discovery as a minor curiosity that belonged in a specialty <span class="txt-wrap">journal.<sup><a href="#fn10" id="r10" class="fn-btn fn-btn-top">10</a></sup></span></p> <p>“There are no experts of the future,” Folkman used to say. Thomas Kuhn went as far as to write that you have to wait for your critics to die. What’s true is that young students approach science with a more open mind. That’s certainly been my experience with mechanobiology.</p> <p class="qst" id="q4">Desite the resistance to your ideas, you managed to break through and get your ideas out. How did you do that?<a class="qst-lnk" href="#q4"><svg viewBox="0 0 16 16" version="1.1" width="16" height="16"><path fill-rule="evenodd" d="M4 9h1v1H4c-1.5 0-3-1.69-3-3.5S2.55 3 4 3h4c1.45 0 3 1.69 3 3.5 0 1.41-.91 2.72-2 3.25V8.59c.58-.45 1-1.27 1-2.09C10 5.22 8.98 4 8 4H4c-.98 0-2 1.22-2 2.5S3 9 4 9zm9-3h-1v1h1c1 0 2 1.22 2 2.5S13.98 12 13 12H9c-.98 0-2-1.22-2-2.5 0-.83.42-1.64 1-2.09V6.25c-1.09.53-2 1.84-2 3.25C6 11.31 7.55 13 9 13h4c1.45 0 3-1.69 3-3.5S14.5 6 13 6z"></path></svg></a></p> <p>I learned early on that science is really a sermon on the mount. People don’t get excited until they hear you speak, then they go back and look you up afterwards, which is why going and meeting other scientists is important. No scientist is willing to admit this, but when you make a good impression on another scientist, they’re more likely to trust your work, and when you don’t, they may never trust your work. It’s a people business.</p> <p>The rise of bioengineering over the course of the last 20–30 years also helped mechanobiology because students began to take engineering courses alongside biology, and mechanics is a big part of engineering.</p> <p>Nevertheless, science is a very conservative business, and to this day mechanobiology is still a small corner of biology while most scientists are happy doing what they’ve always done for the last fifty years.</p> <p>Yet, on the flipside, that’s great news for young scientists because it leaves a lot more for them to discover if they don’t go down the conventional path.</p> <p>I always teach my students that anytime you put forward a new idea, you have to be prepared to do three things:</p> <p>First, you have to learn how to play by the rules of those who control the current paradigm, and show that you can use their tools and get their results.</p> <p>Second, you need to develop a new set of tools that enable you to have rigorous control over the important variables they don’t even see.</p> <p>And third, you must be ready to explain phenomena they can’t explain. My entire career and everthing I’ve done in science is summarized by these three points.</p> <p class="qst" id="q5">You've been critical of peer review publication. what's the situation?<a class="qst-lnk" href="#q5"><svg viewBox="0 0 16 16" version="1.1" width="16" height="16"><path fill-rule="evenodd" d="M4 9h1v1H4c-1.5 0-3-1.69-3-3.5S2.55 3 4 3h4c1.45 0 3 1.69 3 3.5 0 1.41-.91 2.72-2 3.25V8.59c.58-.45 1-1.27 1-2.09C10 5.22 8.98 4 8 4H4c-.98 0-2 1.22-2 2.5S3 9 4 9zm9-3h-1v1h1c1 0 2 1.22 2 2.5S13.98 12 13 12H9c-.98 0-2-1.22-2-2.5 0-.83.42-1.64 1-2.09V6.25c-1.09.53-2 1.84-2 3.25C6 11.31 7.55 13 9 13h4c1.45 0 3-1.69 3-3.5S14.5 6 13 6z"></path></svg></a></p> <p>One of the few silver linings of the COVID-19 crisis is the big change of pace that we’re seeing in science. People are posting their results on the web, and within a few days or weeks, others are either confirming the results or showing them to be unrepeatable. The discussion feels dynamic and the science is speeding nicely ahead.</p> <p>However, that’s not what typically happens in science. A paper usually takes years of delays and revisions to get published, and anything could kill it along the way. An editor might not find it suitable for the journal. Or they might give your interdisciplinary paper to a narrow specialist for review, or worse, to a competing scientist with a conflict of interest. You end up forced to go from journal to journal until you find a good match with one agreeable editor and two reasonable reviewers.</p> <p>More and more onerous demands are also placed on scientists looking to publish in high impact journals. When I started out, a typical <em>Science</em> or <em>Nature</em> paper had, say, a couple of images or a single graph each. Now, the supplementary material alone is 15–20 figures, and that’s on top of what’s already in the paper.</p> <p>That’s five papers’ worth of data for a single article. And putting those datasets together might take 2–3 years. Not only does that badly hold up the advance of science, to say nothing of the all time and money it eats up, but the worst part is that it unfairly punishes young scientists as they can never get their papers out in a timely way in order to land a job.</p> <p>So it’s not surprising that scientists the world over are putting their papers on bioRxiv or medRxiv, where you can easily share your results then immediately turn around and cite your paper in a grant or a follow-up study. As more and more science gets put out there, I suspect that the only question for review journals will eventually be: what’s left?</p> <p>For now, there’s no doubt that review journals remain an important tool for career advancement. Any scientist who wants to land a job, a grant, or a promotion, if not for them then for their students, has little choice but to compete for a spot in a high impact journal. That won’t change until we revisit how scientists are hired and fired.</p> <div class="footnotes"> <ol> <li id="fn1"> <p>Between 1965–1966, György Kepes / kep-ish / edited six anthologies, followed in 1972 by a seventh, all featuring essays from artists, designers, architects, and scientists exploring new directions in education, art, science, and visual communications. <em>Structure in Art and in Science</em> was the second anthology in the series. <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://www.amazon.com/Structure-Art-Science-Gyorgy-Kepes/dp/B001MV203G">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span><a href="#r1" class="fn-btn fn-btn-bot">↩︎</a></p> </li> <li id="fn2"> <p>Investigating the cellular mechanisms that convert mechanical force to biochemical and genetic reactions is now called Mechanotransduction. <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://en.wikipedia.org/wiki/Mechanotransduction">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span><a href="#r2" class="fn-btn fn-btn-bot">↩︎</a></p> </li> <li id="fn3"> <p>Ingber showed experimentally that when a cell stretches flat and anchors itself on a surface, its nucleus is stretched flat as well, and when the anchors are released from the surface, both the cell and the nucleus round up together. This behavior was reproduced by the tensegrity model Ingber built. <a href="#r3" class="fn-btn fn-btn-bot">↩︎</a></p> </li> <li id="fn4"> <p>Integrins are proteins located on the surface of the cell and which serve as mechano-receptors that sense and transmit mechanical force across the surface. See <em>Mechanotransduction across the cell surface and through the cytoskeleton</em>, Wang, Butler, and Ingber, Science, 1993 <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://doi.org/10.1126/science.7684161">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span><a href="#r4" class="fn-btn fn-btn-bot">↩︎</a></p> </li> <li id="fn5"> <p>Ingber and his colleagues used microchips to grow cells on microscopic islands of varying sizes and shapes. By carefully controlling how much space cells were given to grow and expand, their experiments showed that mechanical forces influence cell behaviors such as XYZ. See <em>Engineering cell shape and function</em>, Singhvi et al., Science, 1994, <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://doi.org/10.1126/science.8171320">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span> and <em>Geometric control of cell life and death</em>, Chen et al., Science, 1997 <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://doi.org/10.1126/science.276.5317.1425">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span><a href="#r5" class="fn-btn fn-btn-bot">↩︎</a></p> </li> <li id="fn6"> <p>To make microchips at low cost, Whitesides began by etching patterns onto a chip then pouring a silicon-rubber polymer, letting it cure, then peeling it off, giving him a rubber mold that retained the surface topography of the chip down to the nanometer scale. He used the mold like an ink stamp, inking it with chemicals to stamp out the chip circuit pattern over and over. Ingber adapted the technique by inking the mold with proteins and using it to stamp out small islands of extracellular matrices in which cells could live. <a href="#r6" class="fn-btn fn-btn-bot">↩︎</a></p> </li> <li id="fn7"> <p>Microfluidics is a vast field that remains actively investigated today. Among its various applications, it enabled engineers to miniaturize a plethora of diagnostic devices used in hospital labs from the size of a refrigerator to that of an iPhone. See <em>The origins and the future of microfluidics</em>, Whitesides, Nature, 2006 <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://doi.org/10.1038/nature05058">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span><a href="#r7" class="fn-btn fn-btn-bot">↩︎</a></p> </li> <li id="fn8"> <p>Sepsis, or blood poisoning, is caused by the body’s response to infection and results in damage to tissues and organs, leading to organ failure. It's the most common cause of death in hospitalized patients, killing millions each year. Despite its prevalence, no new therapies have been developed in decades due to repeated failures in clinical trials. Wyss Institute researchers developed an effective treatment by adapting a protein from the human immune system and attached it to nanometer-sized magnetic beads, then using it to bind to pathogens in the blood before getting filtered out by a strong magnet. In all, the system they developed binds more than 110 pathogen species including 15 of the 16 major pathogens that lead to sepsis. <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://wyss.harvard.edu/technology/fcmbl-broad-spectrum-pathogen-capture-for-infectious-diseases/">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span><a href="#r8" class="fn-btn fn-btn-bot">↩︎</a></p> </li> <li id="fn9"> <p>In 1971, Folkman published an article in which he hypothesized that cancer tumors stimulate the creation of new blood vessels nearby in order to feed their rapid growth using a process he labeled “angiogenesis.” His subsequent research focused on cutting off that blood supply to halt or reverse tumor growth. At the time, most cancer research was centered on studying tumor cells, and for over a decade, Folkman’s focus on blood vessels was widely derided and seen as a waste of time. In 2003, 32 years after his original paper, Folkman was fully vindicated when the largest clinical trial in colon cancer patients for an angiogenesis-inhibiting drug was a major success. The drug, called Avastin, was approved by the FDA in 2004. <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://www.tobinproject.org/about/judah-folkman">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span><a href="#r9" class="fn-btn fn-btn-bot">↩︎</a></p> </li> <li id="fn10"> <p>In 1985, Ingber found that a fungus called fumagillin had contaminated a sample of lab-grown vascular cells and was inhibiting their growth. Subsequently, a synthetic analog of the fungus called TNP-470 was found to increase the life expectancy of lung cancer patients by up to 50 percent in early clinical trials, but the drug had flaws. In 2008, TNP-470 was reformulated as an improved oral drug called Lodamin under the supervision of Judah Folkman. It was one of the last projects he led before passing away at the age of 75. <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://www.technologyreview.com/2008/07/11/219649/nanotech-revives-a-cancer-drug/">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span><a href="#r10" class="fn-btn fn-btn-bot">↩︎</a></p> </li> </ol> </div> <hr> <div class="section-headings"> <h2 class="title"><a id="s3">Simulacra</a></h2> <h3 class="head">Tiny chip.<br>True to life.</h3> </div> <figure> <img class="ful-img" alt="A graph of Eroom’s law shows that the cost of developing a new drug roughly doubled every nine years from 1950 through the 2010." id="img-res-int-ingber-3" src="/assets/img/buf.png" data-echo="/assets/img/res-int-ingber-3.jpg"> <figcaption id="img-cap-res-int-ingber-3">This organ-chip is made from clear and flexible silicon rubber and is about the size of an eraser. It contains microfluidic channels lined by living human cells. Its elegantly simple design earned the technology a place in the permanent collection of the Modern Museum of Art in 2015.&nbsp;<span class="credits credits-blk">Wyss Institute</span></figcaption> </figure> <p class="qst" id="q6">Organs-on-chips received early support from DARPA, FDA, NIH, as well as several drug companies. What helped the technology to generate this level of support?<a class="qst-lnk" href="#q6"><svg viewBox="0 0 16 16" version="1.1" width="16" height="16"><path fill-rule="evenodd" d="M4 9h1v1H4c-1.5 0-3-1.69-3-3.5S2.55 3 4 3h4c1.45 0 3 1.69 3 3.5 0 1.41-.91 2.72-2 3.25V8.59c.58-.45 1-1.27 1-2.09C10 5.22 8.98 4 8 4H4c-.98 0-2 1.22-2 2.5S3 9 4 9zm9-3h-1v1h1c1 0 2 1.22 2 2.5S13.98 12 13 12H9c-.98 0-2-1.22-2-2.5 0-.83.42-1.64 1-2.09V6.25c-1.09.53-2 1.84-2 3.25C6 11.31 7.55 13 9 13h4c1.45 0 3-1.69 3-3.5S14.5 6 13 6z"></path></svg></a></p> <p>Over the years, a number of studies showed that at least half of all animal models fail to predict drug results in human patients, while a staggering 90–95 percent of new drugs also fail, which is why pharma executives have taken to describe their business model as “failing quickly and <span class="txt-wrap">cheaply.”<sup><a href="#fn11" id="r11" class="fn-btn fn-btn-top">11</a></sup></span></p> <details open="" id="c1" class="comments-wrapper"> <summary>Editor Comment</summary> <div class="comments"> <p>half of all animals is a conservative estimate taken from this NIH estimate by Collins.</p> <p>The 95 percent figure for failed new drugs comes from a <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101940/">2011 paper</a> by NIH Director Francis Collins. Below is the relevant passage:</p> <blockquote>The average length of time from target discovery to approval of a new drug currently averages ~13 years, <strong>the failure rate exceeds 95%,</strong> and the cost per successful drug exceeds $1 billion, after adjusting for all of the failures.</blockquote> <p>Admittedly, those figures are already dated. Costs have kept climbing past $2B, while the failure rate may have slightly improved by a few percentage points, so a compromise figure might be 90 percent.</p> <div class="comments-nav"> <a class="prev-com" href="#c0">Go to previous</a> <a class="next-com" href="#c2">Go to next</a> </div> </div> </details> <p>So both the FDA and NIH had growing concerns that the situation was unsustainable, and in the last decade, a joint effort began to fund new approaches for testing drug <span class="txt-wrap">toxicity.<sup><a href="#fn12" id="r12" class="fn-btn fn-btn-top">12</a></sup></span></p> <p>In 2010, we published a breakthrough paper in <em>Science</em> discussing the first organ-on-chip we built. It was a lung-chip model of the alveoli that we lined with human lung cells and wired to an air vacuum pump in order to mimic breathing motions.</p> <figure> <video class="ful-vid" id="vid-5" height="100%" autoplay="" muted="" src="/assets/video/buf.mp4" data-echo="/assets/video/res-int-ingber-5.mp4" type="video/mp4"></video> <figcaption id="vid-cap-res-int-ingber-5">The lung-chip models three key features of the real lung: an&nbsp;air-blood interface, breathing motion, and fluid flow.&nbsp;<span class="credits credits-inl">Wyss Institute</span></figcaption> <div class="replay-btn-wrapper"> <button type="button" class="replay-btn-text" id="replay-btn-5" onclick="replayVideo(&quot;vid-5&quot;)">Replay<svg class="replay-btn-icon" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 50 59"><defs></defs><path fill-rule="evenodd" d="M25.13 15H25a19 19 0 1019 19h6A25 25 0 1125.27 9L20.9 3.96 25.4.02l10.5 12.08-.44.38-10.31 11.45-4.46-4.01L25.13 15z"></path></svg></button> </div> </figure> <p>Unlike conventional in vitro models which are static, the addition of breathing motions in our lung-chip caused the cells behave like they would in the human body. They started forming directional cilia and made mucus to clear particles away.</p> <p>We used the model to study microbial infection and lung inflammation, and compared its results with conventional in vitro models and an in vivo mouse model. We found that the lung-chip was able to reproduce the results observed in vivo, meaning it was as accurate as the mouse model and exceedingly better than any in vitro <span class="txt-wrap">model.<sup><a href="#fn13" id="r13" class="fn-btn fn-btn-top">13</a></sup></span></p> <p>Following that paper, DARPA put out a request for proposals that had a picture of our lung-chip model on its cover page before they ever told us about it, so that request had our name on it so to <span class="txt-wrap">speak.<sup><a href="#fn14" id="r14" class="fn-btn fn-btn-top">14</a></sup></span></p> <p>DARPA decided to fund us to the tune of $37M to develop an integrated body-on-chip: ten different organs-chips connected by an automated system and used to predict pharmacokinetics, with the ultimate aim of accelerating drug <span class="txt-wrap">development.<sup><a href="#fn15" id="r15" class="fn-btn fn-btn-top">15</a></sup></span></p> <p>It’s important to note that while DARPA coordinated with the FDA-NIH consortium, it ran its program separately and with one big difference. Aside from our team, they funded one other lab working on organ-on-chip technology with a $25M grant, whereas the FDA and the NIH gave jointly much smaller grants to about 19 groups in total.</p> <p>DARPA gave us five years to complete the project, but we had a fully working body-on-chip by year four. That would have never been possible had DARPA not been decisive in its funding approach from day one, bringing full force to bear on the problem.</p> <p>When it came to the regulatory side, other public agencies were very supportive as well. The FDA made it clear that any regulatory package brought in by a drug company would only need to show that organ-chip models are as good as animal models or better in drug testing.</p> <p>More recently, the FDA also began using organ-on-chip systems from multiple providers at their sites to get familiar with the commercial solutions on offer, and this is true of European agencies as <span class="txt-wrap">well.<sup><a href="#fn16" id="r16" class="fn-btn fn-btn-top">16</a></sup></span></p> <details open="" id="c2" class="comments-wrapper"> <summary>Editor Comment</summary> <div class="comments"> <p>I cross-referenced the 2017 agreement on the <a target="_blank" href="https://www.fda.gov/food/cfsan-constituent-updates/fda-researchers-evaluate-organs-chips-technology">FDA website</a> but I was unable to find any other public agreements with competing providers</p> <p>If there are no such agreements, then I suggest dropping “multiple providers“ and stating that Emulate is the only provider of organ-chip testing equipment to have an agreement so far with the FDA.</p> <p>As for Europe, is there an equivalent agreement to which we can link?</p> <div class="comments-nav"> <a class="prev-com" href="#c1">Go to previous</a> <a class="next-com" href="#c3">Go to next</a> </div> </div> </details> <p>All that remains on the regulatory approval front is for one pharma or biotech company to take the bold step forward and present the FDA with a regulatory package that includes drug testing data from organ-chip models. Once that goes through, the rest of&nbsp;the industry won’t be too far behind and I think we’ll quickly reach the tipping point.</p> <p class="qst" id="q7">The design of organs-on-chips is strikingly simple compared to other approaches to reproduce human physiology. What led you to opt for a simpler design?<a class="qst-lnk" href="#q7"><svg viewBox="0 0 16 16" version="1.1" width="16" height="16"><path fill-rule="evenodd" d="M4 9h1v1H4c-1.5 0-3-1.69-3-3.5S2.55 3 4 3h4c1.45 0 3 1.69 3 3.5 0 1.41-.91 2.72-2 3.25V8.59c.58-.45 1-1.27 1-2.09C10 5.22 8.98 4 8 4H4c-.98 0-2 1.22-2 2.5S3 9 4 9zm9-3h-1v1h1c1 0 2 1.22 2 2.5S13.98 12 13 12H9c-.98 0-2-1.22-2-2.5 0-.83.42-1.64 1-2.09V6.25c-1.09.53-2 1.84-2 3.25C6 11.31 7.55 13 9 13h4c1.45 0 3-1.69 3-3.5S14.5 6 13 6z"></path></svg></a></p> <p>Among the most complicated ways to mimic organ-level physiology is to use tissue engineering and build a living organ in three dimensions to serve as your drug testing model.</p> <p>However, if you did that, you’ll find that it’s difficult to look anywhere you want inside that model and investigate the activities happening in real time at the cellular level. In addition, there are many chemical and mechanical factors that you wouldn’t be able to control. In short, you’d be right back where you started.</p> <p>We took a different approach and tried to distill the problem down to the simplest design principles by asking the question: what makes an organ? And we found that you need three basic conditions.</p> <p>First, two tissues have to come together and form an interface where new functions can emerge. Second, all living tissues need fluid flow to stay alive. And third, it’s hard to get full mimicry without incorporating mechanical motion, like the beating of the heart, the breathing of the lung, or peristalsis in the gut. When we provide these conditions, we are able to mimic human-level physiology and disease states.</p> <p>What’s more, we can control each individual variable. For example, we can add up to four different types of cells and choose what chemical and mechanical factors to introduce, then see how different variables interact and parse what’s important from what’s not.</p> <p>We can also look anywhere we want and go to the same location every time, as if looking through a glass window at the molecular activities taking place in real time inside a&nbsp;cell, a&nbsp;tissue, or an&nbsp;organ.</p> <figure> <video class="ful-vid" id="vid-6" height="100%" autoplay="" muted="" src="/assets/video/buf.mp4" data-echo="/assets/video/res-int-ingber-6.mp4" type="video/mp4"></video> <figcaption id="vid-cap-res-int-ingber-6">Organ-chips are designed to be translucent, providing a new perspective on biological life by revealing the secret inner workings of the living body from moment to moment.&nbsp;<span class="credits credits-inl">Emulate</span></figcaption> <div class="replay-btn-wrapper"> <button type="button" class="replay-btn-text" id="replay-btn-6" onclick="replayVideo(&quot;vid-6&quot;)">Replay<svg class="replay-btn-icon" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 50 59"><defs></defs><path fill-rule="evenodd" d="M25.13 15H25a19 19 0 1019 19h6A25 25 0 1125.27 9L20.9 3.96 25.4.02l10.5 12.08-.44.38-10.31 11.45-4.46-4.01L25.13 15z"></path></svg></button> </div> </figure> <p>Finally, throughput and cost considerations play a major role in drug testing, and our design allows us to leverage industrial manufacturing to offer a robust and scalable solution that offers better economies and more human-relevant results than animal models.</p> <p class="qst" id="q8">Organs-on-chips went from prototype in 2010 to startup in 2014. What important milestones made that turnaround possible? And when did you know that the technology was ready for market?<a class="qst-lnk" href="#q8"><svg viewBox="0 0 16 16" version="1.1" width="16" height="16"><path fill-rule="evenodd" d="M4 9h1v1H4c-1.5 0-3-1.69-3-3.5S2.55 3 4 3h4c1.45 0 3 1.69 3 3.5 0 1.41-.91 2.72-2 3.25V8.59c.58-.45 1-1.27 1-2.09C10 5.22 8.98 4 8 4H4c-.98 0-2 1.22-2 2.5S3 9 4 9zm9-3h-1v1h1c1 0 2 1.22 2 2.5S13.98 12 13 12H9c-.98 0-2-1.22-2-2.5 0-.83.42-1.64 1-2.09V6.25c-1.09.53-2 1.84-2 3.25C6 11.31 7.55 13 9 13h4c1.45 0 3-1.69 3-3.5S14.5 6 13 6z"></path></svg></a></p> <p>Among the first people we recruited to join the Wyss Institute were industry veterans with decades of product development experience, and they proved invaluable in leading the early conversations we had with the pharma industry.</p> <p>We got to learn exactly what the companies were looking for, from the ideal size for an instrument, to how it would be integrated, to which use cases had the most promising opportunities, etc.</p> <p>Because we had ample funding thanks to DARPA, we were also able to do many validation studies with the companies using their own drugs without waiting for grants or corporate budget approvals, and those studies were very encouraging to our partners.</p> <p>Another crucial factor we had was the ability to automate things when needed. Early on, each chip was made by hand, and that led to inconsistent results during drug testing. Two different postdocs running identical tests might get different results. That problem went away as we built automated systems, which allowed us to ramp up testing and expand it to multiple labs.</p> <p>From day one, we knew that this project was on track to be a startup, so we brought in an entrepreneur-in-residence who led a biotech startup once before, and he helped to negotiate two important agreements with the drug companies and pave the way for the commercial venture.</p> <p>Then, in 2014, most of the team working on the technology at the Wyss Institute, about 19 people in total, moved out overnight to join the new startup. They were able to turn the system we built into a small, user-friendly instrument. They eliminated bubbles from the chip-making process, which had been our major nemesis, and figured out how to mass produce the chips using injection-molding and extrusion to keep costs low.</p> <figure> <video class="ful-vid" id="vid-7" height="100%" autoplay="" muted="" src="/assets/video/buf.mp4" data-echo="/assets/video/res-int-ingber-7.mp4" type="video/mp4"></video> <figcaption id="vid-cap-res-int-ingber-7">Using an organ-chip is simple thanks to an automated system that controls the rate of flow and mechanical stretch, and provides the environment cells need to thrive.&nbsp;<span class="credits credits-inl">Emulate</span></figcaption> <div class="replay-btn-wrapper"> <button type="button" class="replay-btn-text" id="replay-btn-7" onclick="replayVideo(&quot;vid-7&quot;)">Replay<svg class="replay-btn-icon" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 50 59"><defs></defs><path fill-rule="evenodd" d="M25.13 15H25a19 19 0 1019 19h6A25 25 0 1125.27 9L20.9 3.96 25.4.02l10.5 12.08-.44.38-10.31 11.45-4.46-4.01L25.13 15z"></path></svg></button> </div> </figure> <p>That work could only be done in a company, so we launched Emulate knowing that it wasn’t all the way there yet, but that we had the proof of principle, the right partners, and the right team.</p> <p class="qst" id="q9">Given the host of technical and ethical challenges with animal models, do you see organs-chips replacing them completely one day, or do the two complement each other?<a class="qst-lnk" href="#q9"><svg viewBox="0 0 16 16" version="1.1" width="16" height="16"><path fill-rule="evenodd" d="M4 9h1v1H4c-1.5 0-3-1.69-3-3.5S2.55 3 4 3h4c1.45 0 3 1.69 3 3.5 0 1.41-.91 2.72-2 3.25V8.59c.58-.45 1-1.27 1-2.09C10 5.22 8.98 4 8 4H4c-.98 0-2 1.22-2 2.5S3 9 4 9zm9-3h-1v1h1c1 0 2 1.22 2 2.5S13.98 12 13 12H9c-.98 0-2-1.22-2-2.5 0-.83.42-1.64 1-2.09V6.25c-1.09.53-2 1.84-2 3.25C6 11.31 7.55 13 9 13h4c1.45 0 3-1.69 3-3.5S14.5 6 13 6z"></path></svg></a></p> <p>In the case of animal models that fail to predict human results, organ-chips will replace those one at a time. For example, while the lung-chip model of the alveoli we first built allows us to study pulmonary edema, we’d need a model of the small airways to study COPD, which we’ve also built. So it’s fit-for-purpose <span class="txt-wrap">design.<sup><a href="#fn17" id="r17" class="fn-btn fn-btn-top">17</a></sup></span></p> <figure> <video class="ful-vid" id="vid-8" height="100%" autoplay="" muted="" src="/assets/video/buf.mp4" data-echo="/assets/video/res-int-ingber-8.mp4" type="video/mp4"></video> <figcaption id="vid-cap-res-int-ingber-8">To study the effects of smoking on COPD patients, Ingber's team built a&nbsp;chain-smoking robot connected to a lung-chip small airways model.&nbsp;<span class="credits credits-blk">Wyss Institute</span></figcaption> <div class="replay-btn-wrapper"> <button type="button" class="replay-btn-text" id="replay-btn-8" onclick="replayVideo(&quot;vid-8&quot;)">Replay<svg class="replay-btn-icon" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 50 59"><defs></defs><path fill-rule="evenodd" d="M25.13 15H25a19 19 0 1019 19h6A25 25 0 1125.27 9L20.9 3.96 25.4.02l10.5 12.08-.44.38-10.31 11.45-4.46-4.01L25.13 15z"></path></svg></button> </div> </figure> <p>In some cases, there no animal models at all. For example, Roche are reducing their animal studies and going to human trials sooner using escalating doses, because their antibodies are now so specific to humans that they don’t affect non-human primates.</p> <p>Of course, there are animal models that won’t be easy to replace in the foreseeable future. Areas such as hormonal cycling, fat deposits, and behavioral models come to mind, but as the technology improves, we should be able to gradually close more and more of that gap, although it’s possible that some animal models may be with us for a long time.</p> <p>The last thing to note is that organs-chips allow us to do things that were never possible with animal models. For example, we can test drugs designed for the unique physiology of developing children, or aging seniors, as well as for small patient groups with rare diseases. All three are cases where animal models are terrible and clinical trials border on impossible.</p> <p class="qst" id="q10">Large-scale phase III clinical trials are the single biggest cost driver of drug testing. Can organs-on-chips help reduce their cost?<a class="qst-lnk" href="#q10"><svg viewBox="0 0 16 16" version="1.1" width="16" height="16"><path fill-rule="evenodd" d="M4 9h1v1H4c-1.5 0-3-1.69-3-3.5S2.55 3 4 3h4c1.45 0 3 1.69 3 3.5 0 1.41-.91 2.72-2 3.25V8.59c.58-.45 1-1.27 1-2.09C10 5.22 8.98 4 8 4H4c-.98 0-2 1.22-2 2.5S3 9 4 9zm9-3h-1v1h1c1 0 2 1.22 2 2.5S13.98 12 13 12H9c-.98 0-2-1.22-2-2.5 0-.83.42-1.64 1-2.09V6.25c-1.09.53-2 1.84-2 3.25C6 11.31 7.55 13 9 13h4c1.45 0 3-1.69 3-3.5S14.5 6 13 6z"></path></svg></a></p> <p>Drug companies spend tens of millions of dollars running huge clinical trials, so when a trial fails, they try to recoup some of their investment by crunching numbers to see if there might be a genetic subgroup on whom the drug would be more effective. If they do end up finding that subgroup, then a few years later, they’ll run another clinical trial to get approval for a narrow application.</p> <p>Organs-on-chips turn that entire model on its head. We can start with a tightly defined genetic subgroup first, then go on to design and test a drug that works well in the organ-chip models using cells from patients in that subgroup before running any trials. What’s more, the better you define the subgroup, the less you need to model every patient, so even with a small sample, we can still get robust results.</p> <p>At that point, if a drug looks promising, we can use a full body-on-chip system to test the pharmacokinetics and drug toxicity and determine the right dosage for phase I and II trials, which could even shorten that part of testing as well.</p> <p>We can also analyse the test results using machine learning to uncover additional parameters to track in patients during the trials, almost like a companion diagnostic that can detect indirect signs of trouble and boost the rate of successful treatment.</p> <p>There’s no question that we’re moving towards a future where this kind of personalized medicine will be on offer, and that will save our healthcare system a fortune on the cost of drug development while giving us the ability to bring new therapies to market faster. The only question is how long the journey takes to get us there, and that has more to do with commercial adoption than technology at this point.</p> <p class="qst" id="q11">DARPA envisioned using organs-on-chips to mount a rapid response against biothreats. How has COVID-19 put that vision to the test?<a class="qst-lnk" href="#q11"><svg viewBox="0 0 16 16" version="1.1" width="16" height="16"><path fill-rule="evenodd" d="M4 9h1v1H4c-1.5 0-3-1.69-3-3.5S2.55 3 4 3h4c1.45 0 3 1.69 3 3.5 0 1.41-.91 2.72-2 3.25V8.59c.58-.45 1-1.27 1-2.09C10 5.22 8.98 4 8 4H4c-.98 0-2 1.22-2 2.5S3 9 4 9zm9-3h-1v1h1c1 0 2 1.22 2 2.5S13.98 12 13 12H9c-.98 0-2-1.22-2-2.5 0-.83.42-1.64 1-2.09V6.25c-1.09.53-2 1.84-2 3.25C6 11.31 7.55 13 9 13h4c1.45 0 3-1.69 3-3.5S14.5 6 13 6z"></path></svg></a></p> <p>Two years ago, we received a grant from the DARPA Prepare program to develop new RNA and CRISPR-based therapeutics for unexpected viral pandemics using our organ-chip models. The focus was largely on&nbsp;Influenza, as it seemed the most likely threat at the <span class="txt-wrap">time.<sup><a href="#fn18" id="r18" class="fn-btn fn-btn-top">18</a></sup></span></p> <p>Using a lung airway chip, we mimicked the virulence of three common strains of influenza, H1N1, H3N2, and H5N1, and measured the cytokine response. We reproduced human-to-human transmission by infecting a healthy chip with fluid taken from an infected chip. We also showed viral evolution over time and identified known mutations of resistance to drugs found in humans as well as novel mutations never seen before.</p> <p>Then, we introduced immune cells and observed as they got recruited and cleared the virus in real time. We used anti-viral drugs like Tamiflu and showed that you get the same two-day time window of action as in humans. We also repurposed an anti-coagulant called Nafamostat and showed that it doubled that time window to 96 hours.</p> <p>This was the first time that organ-chip models were used in this way to study a viral disease like influenza, yet we still couldn’t get a single paper published in a journal. Reviewers didn’t think the work was novel or important enough. However, when COVID-19 struck, we were well prepared to take what we learned and redouble our efforts against the new virus.</p> <p>On January 12th, the SARS-CoV-2 genome was uploaded from China. In one day, a virologist on our team made a pseudovirus that expresses the CoV-2 spike protein, allowing us to safely begin studying the virus in our BSL-2 lab, since we couldn’t work directly with the live <span class="txt-wrap">virus.<sup><a href="#fn19" id="r19" class="fn-btn fn-btn-top">19</a></sup></span></p> <figure> <img class="ful-img" alt="A graph of Eroom’s law shows that the cost of developing a new drug roughly doubled every nine years from 1950 through the 2010." id="img-res-int-ingber-4" src="/assets/img/buf.png" data-echo="/assets/img/res-int-ingber-4.jpg"> <figcaption id="img-cap-res-int-ingber-4">Coronaviruses, such as SARS-CoV-2 seen here, get their name from the crown-like protein spikes on the outer edge of their particles. A counter-strategy used effectively against them is to look for drug molecules that bind to those spikes and prevent the virus from infiltrating cells to replicate.&nbsp;<span class="credits credits-inl">NIAID</span></figcaption> </figure> <p>We first prioritized testing eight drugs that were previously shown to inhibit infection of related viruses, like SARS-CoV-1, Ebola, and MERS. After infecting our lung airway chips with the pseudovirus, the drugs were administered at the clinically relevant dose, and of the eight we tested, three worked.</p> <p>Of those three, one is a chloroquine-related drug that was confirmed to work against the live virus in a collaborating BSL-3 lab. Since then, we’ve tested the drug in animal models and got very good <span class="txt-wrap">results.<sup><a href="#fn20" id="r20" class="fn-btn fn-btn-top">20</a></sup></span></p> <details open="" id="c3" class="comments-wrapper"> <summary>Editor Comment</summary> <div class="comments"> <p>I’m deliberately ommitting any mention of specific drug names.</p> <div class="comments-nav"> <a class="prev-com" href="#c2">Go to previous</a> <a class="next-com" href="#c4">Go to next</a> </div> </div> </details> <p>In tandem, other members of the team took a computational approach, using highly accurate computer simulations of molecular dynamics to identify existing FDA-approved drugs and novel compounds that bind to the CoV-2 spike protein and which could be tested in lung-chip models.</p> <p>A second computational effort was kicked off in February with a grant to use machine learning algorithms and sift through data on the gene expression patterns of tens of thousands of known drug compounds, identifying those that have the best potential to revert a disease-state expression pattern back to its normal state. That effort is being led by Jim Collins and his team.</p> <p>We incorporated these two computational approaches into our testing pipeline, which has screened to date 364 drugs, of which more than 65 drugs are already in clinical trials around the world.</p> <p>We’re having weekly updates with DARPA, the Gates Foundation, and several public agencies to coordinate our efforts until the immediate crisis is resolved. We’re also part of many discussions looking at long-term strategies to raise our state of readiness against biothreats.</p> <p>For example, this crisis has shown the need to ramp up the integration of organs-on-chips into BSL-3 labs across the U.S., including CDC and military labs. In a time-sensitive situation such as this one, the sooner we start testing human-relevant models, the faster we can respond.</p> <p>However, to make the most of the capabilities that organ-chip models provide, we also need to see much more cross-validation with clinical studies, not just during this crisis but as a larger goal moving forward. Just as animal models are a key step on the way to a clinical study, we need to get to a point when organ-chip models can inform the decision to run clinical <span class="txt-wrap">studies.<sup><a href="#fn21" id="r21" class="fn-btn fn-btn-top">21</a></sup></span></p> <details open="" id="c4" class="comments-wrapper"> <summary>Editor Comment</summary> <div class="comments"> <p>The footnote above links to your 2020 paper titled <em>Human Organs-on-Chips for Virology</em>, but another good choice might be the paper you've mentioned a few times already, whose title begins with <em>“Is it time for reviewer 3 to ask for..“</em></p> <p>I can’t find a link to that paper, but if it’s published, we can link to it.</p> <div class="comments-nav"> <a class="prev-com" href="#c3">Go to previous</a> <a class="next-com" href="#c5">Go to next</a> </div> </div> </details> <p>The good news is that we’re already starting to see progress in both of those areas, but whether it will be enough or not remains to be seen. If we draw the right lessons from the COVID-19 calamity and improve our systems accordingly, then this terrible pandemic and the tragic loss of life would not have been for nothing.</p> <div class="footnotes"> <ol> <li id="fn11"> <p>We discuss at length the problems surrounding the failure of drug R&amp;D over the last six decades in our interview with Jack Scannell, who coined the term Eroom's law in 2012 to describe this decline. See <em>Life after Eroom's law</em>, Refoundable, 2020 <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://www.refoundable.com/research/life-after-erooms-law-interview-with-jack-scannell">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span><a href="#r11" class="fn-btn fn-btn-bot">↩︎</a></p> </li> <li id="fn12"> <p> <em>U.S. to develop chip that tests if a drug is toxic</em>, Reuters, 2011 <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://www.reuters.com/article/us-drugs-chip-idUSTRE78F5KX20110916">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span><a href="#r12" class="fn-btn fn-btn-bot">↩︎</a></p> </li> <li id="fn13"> <p>Ingber's team showed that the lung-chip alveoli model could mimic the human immune response to microbial infection. They also explored the model's potential for testing toxicity by investigating the pulmonary response to airborne nanoparticulates, which are known to cause lung inflammation. They found that the presence of breathing motions raised the absorption rate of nanoparticles fivefold compared to static in vitro models. See <em>Reconstituting Organ-Level Lung Functions on a Chip</em>, Huh et al., Science, 2010 <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://doi.org/10.1126/science.1188302">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span><a href="#r13" class="fn-btn fn-btn-bot">↩︎</a></p> </li> <li id="fn14"> <p> <em>Microphysiological Systems</em>, DARPA, 2012 <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://www.darpa.mil/program/microphysiological-systems">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span><a href="#r14" class="fn-btn fn-btn-bot">↩︎</a></p> </li> <li id="fn15"> <p>By the end of the project, the Wyss Institute had 12 organ-chip models in development representing the following organ functions: skin, brain, blood-brain barrier, lung alveoli, lung small airways, heart, liver, small intestines, large intestines, kidney proximal tubule, kidney glomerulus, and bone marrow. See <em>Wyss Institute to receive up to $37 Million from DARPA to integrate multiple organ-on-chip systems to mimic the whole human body</em>, Wyss Institute, 2012 <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://wyss.harvard.edu/news/wyss-institute-to-receive-up-to-37-million-from-darpa-to-integrate-multiple-organ-on-chip-systems-to-mimic-the-whole-human-body/">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span><a href="#r15" class="fn-btn fn-btn-bot">↩︎</a></p> </li> <li id="fn16"> <p> <em>FDA signs collaborative agreement with Emulate, Inc. to use organs-on-chips technology as a toxicology testing platform</em>, Emulate, 2017 <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://www.emulatebio.com/press/fda-collab-agreement-emulate">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span><a href="#r16" class="fn-btn fn-btn-bot">↩︎</a></p> </li> <li id="fn17"> <p>See <em>Mimicking life-like cigarette smoke exposure and patient-specific responses in human lung airway chips</em>, Wyss Institute, 2016 <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://wyss.harvard.edu/news/mimicking-life-like-cigarette-smoke-exposure-and-patient-specific-responses-in-human-lung-airway-chips/">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span><a href="#r17" class="fn-btn fn-btn-bot">↩︎</a></p> </li> <li id="fn18"> <p> <em>Dialing up the body’s defenses against public health and national security threats</em>, DARPA, 2018 <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://www.darpa.mil/news-events/2018-05-25">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span><a href="#r18" class="fn-btn fn-btn-bot">↩︎</a></p> </li> <li id="fn19"> <p>Studies performed on dangerous live viruses like the novel SARS-CoV-2 are restricted to labs that meet the strictest biosafety requirements, namely those with BSL-3 or BSL-4 ratings. Since most research facilities don't meet those stringent requirements, another recourse is to use a pseudovirus, which can be artificially made using DNA fragments to mimic the surface proteins of a native virus without its virulence, making it safer to handle. <a href="#r19" class="fn-btn fn-btn-bot">↩︎</a></p> </li> <li id="fn20"> <p> <em>Human organ chip-enabled pipeline to rapidly repurpose therapeutics during viral pandemics</em>, Si et al., BioRxiv, 2020 <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://doi.org/10.1101/2020.04.13.039917">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span><a href="#r20" class="fn-btn fn-btn-bot">↩︎</a></p> </li> <li id="fn21"> <p>See <em>Human Organs-on-Chips for Virology</em>, Tang et al., Trends in Microbiology, 2020 <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://doi.org/10.1016/j.tim.2020.06.005">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span><a href="#r21" class="fn-btn fn-btn-bot">↩︎</a></p> </li> </ol> </div> <hr> <div class="section-headings"> <h2 class="title"><a id="s4">Integration</a></h2> <h3 class="head">Some assembly<br>required.</h3> </div> <p class="qst" id="q12">lorem ipsum platforms?<a class="qst-lnk" href="#q12"><svg viewBox="0 0 16 16" version="1.1" width="16" height="16"><path fill-rule="evenodd" d="M4 9h1v1H4c-1.5 0-3-1.69-3-3.5S2.55 3 4 3h4c1.45 0 3 1.69 3 3.5 0 1.41-.91 2.72-2 3.25V8.59c.58-.45 1-1.27 1-2.09C10 5.22 8.98 4 8 4H4c-.98 0-2 1.22-2 2.5S3 9 4 9zm9-3h-1v1h1c1 0 2 1.22 2 2.5S13.98 12 13 12H9c-.98 0-2-1.22-2-2.5 0-.83.42-1.64 1-2.09V6.25c-1.09.53-2 1.84-2 3.25C6 11.31 7.55 13 9 13h4c1.45 0 3-1.69 3-3.5S14.5 6 13 6z"></path></svg></a></p> <p>We launched the Wyss Institute with 14 founding faculty members who had a broad range of expertise and interests spanning across biology, clinical medicine, chemistry, computer science and robotics, virtually all fields of engineering, and much more.</p> <p>Our overarching goal was to leverage the design principles nature uses, such as tensegrity, in order to develop new engineering solutions, for both medical and non-medical applications. That was an approach we called “biologically inspired engineering,” and we started by organizing our research efforts around a number of big focus areas such as living cellular devices, synthetic biology, molecular robotics, and a few more.</p> <p>Each focus area has teams of faculty, postdoctoral fellows, graduate students, and technical staff working to develop new capabilities, that is, new tools and methods that can drive the next wave of innovations in bioinspired materials and devices.</p> <figure> <img class="ful-img" alt="A graph of Eroom’s law shows that the cost of developing a new drug roughly doubled every nine years from 1950 through the 2010." id="img-res-int-ingber-5" src="/assets/img/buf.png" data-echo="/assets/img/res-int-ingber-5.jpg"> <figcaption id="img-cap-res-int-ingber-5">Inspired by the biology of a fly, these robotic insects achieve vertical takeoff, hovering, and steering thanks to two wafer-thin wings that flap at 120 times per second. Each wing is controlled independently in real-time. Could perform myriad roles in agriculture or disaster relief.&nbsp;<span class="credits credits-inl">Wyss Institute</span></figcaption> </figure> <p>New focus areas are never imposed from the top down. Instead, when a core faculty has a visionary idea for an area, we enable them to try it. Sometimes that might involve asking the heads of other areas to take a small budget cut. Still, we’ve never had an issue because the faculty know just how much value a new focus area brings to the Institute as a&nbsp;whole.</p> <p>For example, when David Walt joined as a core faculty, he had a vision for a “diagnostics accelerator” that would identify the unmet needs of clinicians and accelerate the translation of new technologies that can satisfy those needs into the <span class="txt-wrap">clinic.<sup><a href="#fn22" id="r22" class="fn-btn fn-btn-top">22</a></sup></span></p> <p>That vision became a Wyss Institute initiative that Walt is now leading in close collaboration with his lab at Brigham and Women’s Hospital in Boston, allowing us to validate the technologies we develop with hard clinical data.</p> <p class="qst" id="q13">The Wyss Institute tries to combine the novelty of academic research with the practicality of industry. Why is the integration important?<a class="qst-lnk" href="#q13"><svg viewBox="0 0 16 16" version="1.1" width="16" height="16"><path fill-rule="evenodd" d="M4 9h1v1H4c-1.5 0-3-1.69-3-3.5S2.55 3 4 3h4c1.45 0 3 1.69 3 3.5 0 1.41-.91 2.72-2 3.25V8.59c.58-.45 1-1.27 1-2.09C10 5.22 8.98 4 8 4H4c-.98 0-2 1.22-2 2.5S3 9 4 9zm9-3h-1v1h1c1 0 2 1.22 2 2.5S13.98 12 13 12H9c-.98 0-2-1.22-2-2.5 0-.83.42-1.64 1-2.09V6.25c-1.09.53-2 1.84-2 3.25C6 11.31 7.55 13 9 13h4c1.45 0 3-1.69 3-3.5S14.5 6 13 6z"></path></svg></a></p> <p>Companies readily reinvest their capital in a proven product line over a risky idea in an untested market. In contrast, academia has no trouble generating a wealth of creative and risky ideas, but it lacks the focus to adapt the most promising ones into useful applications.</p> <p>Academic researchers are not trained to patent the technologies they invent, and their career advancement is not linked to their success at reducing innovations to practice.</p> <p>At the Wyss Institute, we train all of our researchers to write reports of inventions as early in the development phase as possible. The reports go to a intellectual property attorney on site who reviews every report and offers feedback to focus the investigators’ research efforts on the shortest path to new technology that would be worthy of a patent.</p> <p>Another problem plaguing the academy is that publicly-funded grants often go to support incremental advances in science while the boldest ideas rarely get the support they need. As a result, it’s not uncommon to see researchers working on their most exciting ideas in their spare time between different grant projects.</p> <p>So when we started the Wyss Institute, we recruited faculty members who had done lots of interdisciplinary work in spite of the system, and we structured the Institute to turbocharge their work by removing any hurdles in the way.</p> <p>For example, we don’t ask our faculty members to give up their own lab at their home institution when they join the Wyss Institute. In fact, we want them to maintain their independent culture and move their most entrepreneurial postdoctoral fellows, graduate students, and research assistants to our site where they can benefit from working with other faculty groups.</p> <p>We make collaboration easier by having all of our faculty members and staff in one large open lab, allowing experts from different disciplines, who normally have no reason to work together, to start talking to each other and organically form interdisciplinary teams to work on solving a particular problem.</p> <p>We also provide a sophisticated machine shop staffed by experienced full-time engineers, something you won’t find in most medical schools or academic labs. It houses cutting-edge manufacturing equipment that enable us to prototype and build virtually any type of device, from a soft robot to a living microchip, and choose from an extensive range of materials, including many which are approved by the FDA for use in medical applications.</p> <p>In addition, we recruited 40 technical staff scientists and engineers to join the Wyss Institute from industry. Each brings years to decades of product development experience from companies like AstraZeneca, GlaxoSmithKlein, Pfizer, Biogen, iRobot, Pratt &amp; Whitney, and Procter &amp; Gamble among others.</p> <p>Of course, technical staff are part of any major research institute, but while they’re usually assigned to run the research facilities, we prefer to integrate them into our development teams.</p> <p>The result is that when, for example, one of our scientists goes looking for a material that has particular physical properties, the answer might might readily come from one of our technical staff who encountered a material with similar properties under a very different setting.</p> <p>That capability, combined with the experience of our technical staff in developing aggressive timelines and consistently meeting milestones, dramatically boosts the ability of our research teams to reduce their innovations to practice at a pace rarely seen in academia.</p> <p class="qst" id="q14">Being too early to market is always a risk when working with cutting-edge research. How do you strike the right balance between frontier innovation and good timing?<a class="qst-lnk" href="#q14"><svg viewBox="0 0 16 16" version="1.1" width="16" height="16"><path fill-rule="evenodd" d="M4 9h1v1H4c-1.5 0-3-1.69-3-3.5S2.55 3 4 3h4c1.45 0 3 1.69 3 3.5 0 1.41-.91 2.72-2 3.25V8.59c.58-.45 1-1.27 1-2.09C10 5.22 8.98 4 8 4H4c-.98 0-2 1.22-2 2.5S3 9 4 9zm9-3h-1v1h1c1 0 2 1.22 2 2.5S13.98 12 13 12H9c-.98 0-2-1.22-2-2.5 0-.83.42-1.64 1-2.09V6.25c-1.09.53-2 1.84-2 3.25C6 11.31 7.55 13 9 13h4c1.45 0 3-1.69 3-3.5S14.5 6 13 6z"></path></svg></a></p> <p>In the early days, having industry veterans on our development teams meant that we reached out to companies and got their feedback much sooner. We also frequently brought in entrepreneurs-in-residence to projects, and they talked to venture capitalists early on as well.</p> <p>After seeing a number of those early discussions, we realized that we could triangulate what investors and companies needed to close the deal, so we launched a program called “Institute Projects.”</p> <p>Before a development team can continue to develop their project and request funds from the Wyss Institute, they have to turn the feedback they got from investors and companies into a clear plan that identifies how the technology should be developed in order to warrant venture capital funding and increase the likelihood of commercial success.</p> <p>Teams that do qualify can request funds to recruit entrepreneurs-in-residence with domain-specific expertise to lead the team, as well as to carry out late-stage validation efforts, like reducing manufacturing costs, demonstrating buy-in from clinicians, conducting a regulatory and market analysis, and running phase I clinical trials.</p> <p>The program was a great success, and we soon realized that there was a void between the early research and Institute Projects, so to bridge that gap, we started a second program called “Validation Projects.”</p> <p>There, the goal is to identify new technologies in the pipeline that have gone through significant concept refinement to be able to meet some technical, intellectual property, and product development criteria. The focus of the teams that qualify then turns to de-risking the technology and integrating business development expertise to validate both the applicability and market potential of the technology.</p> <p>The result is a translation funnel that moves in stages from complete creative freedom in the early research phase to a well-defined product roadmap by the time you get to commercialization.</p> <p>Of course, the stages are not designed to be rigid and crossovers do happen, as in the case of organs-on-chips, where DARPA’s $37M grant carried the technology across the entire funnel, from the benchtop all the way to the market. That was truly an idea whose time had come.</p> <p class="qst" id="q15">The Wyss Institute coordinates with a dozen different partners, from academic institutions to hospitals, to take innovations out of the lab. How do you keep everyone's incentives aligned?<a class="qst-lnk" href="#q15"><svg viewBox="0 0 16 16" version="1.1" width="16" height="16"><path fill-rule="evenodd" d="M4 9h1v1H4c-1.5 0-3-1.69-3-3.5S2.55 3 4 3h4c1.45 0 3 1.69 3 3.5 0 1.41-.91 2.72-2 3.25V8.59c.58-.45 1-1.27 1-2.09C10 5.22 8.98 4 8 4H4c-.98 0-2 1.22-2 2.5S3 9 4 9zm9-3h-1v1h1c1 0 2 1.22 2 2.5S13.98 12 13 12H9c-.98 0-2-1.22-2-2.5 0-.83.42-1.64 1-2.09V6.25c-1.09.53-2 1.84-2 3.25C6 11.31 7.55 13 9 13h4c1.45 0 3-1.69 3-3.5S14.5 6 13 6z"></path></svg></a></p> <p>When we approached our first partners, the timing played in our favor. Four months before we launched in January 2009, Lehman Brothers had filed for bankruptcy. Eight billion dollars of Harvard’s endowment had vanished. Hospitals were extremely concerned. Amid this chaos, we came in with the very generous gift of $125M from Hansjörg Wyss. We had only five years to prove our model before the funding ran out, so we were eager to start, and as it turned out, so was everyone else.</p> <p>I was at Boston Children’s Hospital for years before founding the Wyss Institute, so I knew that partnering with hospitals in the area would be absolutely critical, and my existing relationships gave us a head start. We were proposing to bring engineering to the heart of the Longwood Medical Area, and that was a new experience for the hospitals, so they were very keen on getting involved.</p> <p>The discussions we had helped us learn a great deal from the previous agreements the hospitals made with other research centers. We took note of what was working well, and made some adjustments to better suit the translation focus of our partnerships.</p> <p>For example, one of the biggest barriers to commercial collaboration is managing intellectual property and sharing revenues. Anytime two institutions want to collaborate on a commercial project, they have to draft a new agreement in order to manage any intellectual property arising from that collaboration, which takes a long time.</p> <p>So we decided to create a single governing agreement that applies to any partner who joins. Anytime the agreement is changed, everyone gets the same benefit. By doing that, we eliminated the need for side agreements, which are often a big source of misalignment.</p> <p>Another area where misalignment can creep in is faculty appointment. There, the model we went with gives each institution the right to send one faculty member to the Wyss Institute after joining the agreement. From that point forward, every additional faculty member sent by the institution would require an allocation of funds to go with it, and that turns out to be a very effective way to ensure that the growth of our faculty is well justified.</p> <p>Once we had all the right pieces in place, starting new collaborations became much easier, and we could pursue partnerships that emerged from the bottom-up based on the working relationships and common interests that other institutions had with members of our faculty.</p> <p>The benefits of our collaborations also extended to our startups. Every startup has to be intently focused and diligent with its capital to have a shot at success, and we stretch every last penny of capital that goes to one of our startups by marshaling the combined resources of the Wyss Institute, Harvard University, and all of our institutional partners.</p> <p>Together, we help our startups continue to validate their products, use powerful and expensive tools at our sites, tap into existing intellectual property, and call in the expert help of our faculty to assist with thorny technical problems.</p> <p>Because we all share a common goal and stand to benefit when one of us or our startups does well, the collaborations are honest and intense, and they come together in the end and build something that is greater than the sum of its parts, or as I prefer to call it, a tensegrity.</p> <div class="footnotes"> <ol> <li id="fn22"> <p>In 1998, David Walt co-founded Illumina, the market leader in DNA sequencing technology. In 2007, he co-founded Quanterix, which builds advanced diagnostics tools for precision medicine. Walt joined the Wyss Institute in 2017. See <em>Wyss Institute welcomes David Walt, scientific founder of Illumina and Quanterix, as newest core faculty member</em>, Wyss Institute, 2017 <span class="txt-wrap"><a class="fn-ext-lnk" target="_blank" href="https://wyss.harvard.edu/news/wyss-institute-welcomes-david-walt-scientific-founder-of-illumina-and-quanterix-as-newest-core-faculty-member/">Learn more</a><svg xmlns="http://www.w3.org/2000/svg" class="icon-fn-external-lnk" viewBox="0 0 341 341"><defs></defs><path d="M325 0H69v32h217L0 318l23 23L309 55v201h32V16c0-9-7-16-16-16z"></path></svg></span><a href="#r22" class="fn-btn fn-btn-bot">↩︎</a></p> </li> </ol> </div> <hr class="hr-true"> </article> <div class="essay-equiv"> </div> <div style="display:none"><span class="essay-nav-scroll"></span><span class="essay-btn-scroll"></span></div> </main> <footer id="footer-main" class="footer footer-light"> <div class="return-top"><a href="#top"><svg xmlns="http://www.w3.org/2000/svg" class="back-to-top-arrow fill-slvr rot-up" viewBox="0 0 476 267"><defs></defs><path d="M238 209L447 0l29 29-238 238v-1 1L0 29 29 0l209 209z"></path></svg></a></div> <p>© 2019–<span id="current-year">2020</span> Refoundable LP</p> <ul> <li> <a href="/privacy">Privacy</a> </li> <li> <a href="/terms">Terms</a> </li> <li> <a href="/about#contact">Contact</a> </li> </ul> </footer> <script></script> <script>function stickyNav(){var e=document.getElementById("sticky-nav"),t=document.getElementsByClassName("sticky-btn");if(45<document.body.scrollTop||45<document.documentElement.scrollTop){e.classList.add("essay-nav-scroll");for(var s=0;s<t.length;s++)t[s].classList.add("essay-btn-scroll")}else for(e.classList.remove("essay-nav-scroll"),s=0;s<t.length;s++)t[s].classList.remove("essay-btn-scroll")}function replayVideo(e){var t=document.getElementById(e);t.paused&&t.play()}document.getElementById&&(onload=function(){setInterval("document.getElementById('current-year').firstChild.data = new Date().getFullYear()")})</script> <script>"serviceWorker"in navigator&&"refoundable.com"===window.location.hostname&&navigator.serviceWorker.register("/service-worker.js").then(function(e){console.log("ServiceWorker registration successful with scope: ",e.scope)}).catch(function(e){console.log("ServiceWorker registration failed: ",e)})</script> <script>!function(t,e){"function"==typeof define&&define.amd?define(function(){return e(t)}):"object"==typeof exports?module.exports=e:t.echo=e(t)}(this,function(u){"use strict";function d(t,e){if(function(t){return null===t.offsetParent}(t))return!1;var n=t.getBoundingClientRect();return n.right>=e.l&&n.bottom>=e.t&&n.left<=e.r&&n.top<=e.b}function c(){!i&&t||(clearTimeout(t),t=setTimeout(function(){s.render(),t=null},a))}var l,t,a,i,f,s={},h=function(){};return s.init=function(t){function e(t,e){return parseInt(t||e,10)}var n=(t=t||{}).offset||0,o=t.offsetVertical||n,r=t.offsetHorizontal||n;l={t:e(t.offsetTop,o),b:e(t.offsetBottom,o),l:e(t.offsetLeft,r),r:e(t.offsetRight,r)},a=e(t.throttle,250),i=!1!==t.debounce,f=!!t.unload,h=t.callback||h,s.render(),document.addEventListener?(u.addEventListener("scroll",c,!1),u.addEventListener("load",c,!1)):(u.attachEvent("onscroll",c),u.attachEvent("onload",c))},s.render=function(t){for(var e,n,o=(t||document).querySelectorAll("[data-echo], [data-echo-background]"),r=o.length,c={l:0-l.l,t:0-l.t,b:(u.innerHeight||document.documentElement.clientHeight)+l.b,r:(u.innerWidth||document.documentElement.clientWidth)+l.r},a=0;a<r;a++)n=o[a],d(n,c)?(f&&n.setAttribute("data-echo-placeholder",n.src),null!==n.getAttribute("data-echo-background")?n.style.backgroundImage="url("+n.getAttribute("data-echo-background")+")":n.src!==(e=n.getAttribute("data-echo"))&&(n.src=e),f||(n.removeAttribute("data-echo"),n.removeAttribute("data-echo-background")),h(n,"load")):f&&(e=n.getAttribute("data-echo-placeholder"))&&(null!==n.getAttribute("data-echo-background")?n.style.backgroundImage="url("+e+")":n.src=e,n.removeAttribute("data-echo-placeholder"),h(n,"unload"));r||s.detach()},s.detach=function(){document.removeEventListener?u.removeEventListener("scroll",c):u.detachEvent("onscroll",c),clearTimeout(t)},s})</script> <script>echo.init({offset:2500,throttle:250,unload:!1,callback:function(t,o){}})</script></body></html>